Study ID	Patient ID	Sample ID	Age at Sample Collection	Androgen Deprivation Therapy (ADT)	Archer Panel	Biopsy Gleason Grade	Cancer Type	Cancer Type Detailed	Timing of metastases	Disease Extent	Disease volume	Fraction Genome Altered	Gene Panel	Institute Source	Castration Resistance Event	MSI Comment	MSI Score	MSI Type	MSK Slide ID	Mutation Count	Oncotree Code	Overall Survival since Sample Collection (Months)	12-245 Part A Consented	12-245 Part C Consented	MSK Pathology Slide Available	Pediatric Case Indicator	Prostate-specific antigen	Race Category	Sample Class	Number of Samples Per Patient	Sample coverage	Sex	Time from sample to castration resistance [months]	Somatic Status	SO comments	Survival Status	Tissue Site	TMB (nonsynonymous)	Tumor Purity
prad_mcspc_mskcc_2020	P-0000373	P-0000373-T01-IM3	55	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0023	IMPACT341	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.09	Stable	472020	1	PRAD	38.75	YES	YES	YES	No	6	White	Tumor	1	708	Male	20.03	Matched	NA	Dead	Lymph Node	1.109155301	60
prad_mcspc_mskcc_2020	P-0000431	P-0000431-T01-IM3	57	Yes	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.1985	IMPACT341	MSKCC	Yes	NA	0.34	Stable	473451	1	PRAD	59.48	YES	YES	YES	No	11	White	Tumor	1	530	Male	35.58	Matched	NA	Alive	Lymph Node	1.109155301	60
prad_mcspc_mskcc_2020	P-0000442	P-0000442-T01-IM3	67	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1419	IMPACT341	MSKCC	No	NA	0.18	Stable	474027	1	PRAD	56.29	YES	YES	YES	No	90	White	Tumor	1	922	Male	56.29	Matched	NA	Alive	Prostate	1.109155301	50
prad_mcspc_mskcc_2020	P-0000509	P-0000509-T01-IM3	64	Yes	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0161	IMPACT341	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.17	Stable	478159	2	PRAD	69.5	YES	YES	YES	No	21	White	Tumor	1	651	Male	39.84	Matched	NA	Alive	Prostate	2.218310601	50
prad_mcspc_mskcc_2020	P-0000541	P-0000541-T01-IM3	57	Yes	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.3134	IMPACT341	MSKCC	Yes	NA	0.36	Stable	744573	3	PRAD	46.9	YES	YES	YES	No	32	White	Tumor	1	515	Male	21.58	Matched	NA	Dead	Prostate	3.327465902	60
prad_mcspc_mskcc_2020	P-0000659	P-0000659-T01-IM3	71	Yes	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.2003	IMPACT341	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.84	Stable	472152	4	PRAD	50.9	YES	NO	YES	No	4	White	Tumor	1	1267	Male	10.93	Matched	NA	Dead	Lymph Node	4.436621202	60
prad_mcspc_mskcc_2020	P-0000675	P-0000675-T01-IM3	54	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0000	IMPACT341	MSKCC	No	NA	0	Stable	470755	2	PRAD	50.77	YES	NO	YES	No	1	NA	Tumor	1	616	Male	50.77	Matched	NA	Alive	Prostate	2.218310601	30
prad_mcspc_mskcc_2020	P-0000683	P-0000683-T01-IM3	66	Yes	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.4323	IMPACT341	MSKCC	Yes	NA	3.91	Indeterminate	470792	6	PRAD	15.29	YES	NO	YES	No	8	White	Tumor	1	256	Male	1.81	Matched	NA	Dead	Prostate	6.654931804	30
prad_mcspc_mskcc_2020	P-0000842	P-0000842-T01-IM3	64	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.0325	IMPACT341	MSKCC	Yes	NA	0.73	Stable	478809	1	PRAD	21.97	YES	YES	YES	No	1500	White	Tumor	1	242	Male	4.43	Matched	NA	Dead	Prostate	1.109155301	75
prad_mcspc_mskcc_2020	P-0000888	P-0000888-T01-IM3	60	Yes	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.4844	IMPACT341	MSKCC	Yes	NA	1.84	Stable	478995	1	PRAD	9.1	YES	NO	YES	No	4	White	Tumor	1	902	Male	0.4	Matched	NA	Dead	Lymph Node	1.109155301	70
prad_mcspc_mskcc_2020	P-0001092	P-0001092-T01-IM3	54	Yes	NO	NA	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.3876	IMPACT341	MSKCC	Yes	NA	1.28	Stable	744665	6	PRAD	37.35	YES	YES	YES	No	9	White	Tumor	1	1068	Male	3.65	Matched	NA	Dead	Lymph Node	6.654931804	50
prad_mcspc_mskcc_2020	P-0001128	P-0001128-T01-IM3	63	No	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.0257	IMPACT341	MSKCC	No	NA	0.17	Stable	500923	7	PRAD	22.67	YES	NO	YES	No	19	White	Tumor	1	373	Male	12.83	Matched	NA	Alive	Prostate	7.764087104	35
prad_mcspc_mskcc_2020	P-0001141	P-0001141-T01-IM3	73	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.4983	IMPACT341	MSKCC	No	NA	1.23	Stable	745278	3	PRAD	59.35	YES	NO	YES	No	18	NA	Tumor	1	730	Male	49.33	Matched	NA	Alive	Liver	3.327465902	40
prad_mcspc_mskcc_2020	P-0001153	P-0001153-T01-IM3	72	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.1875	IMPACT341	MSKCC	No	NA	0	Stable	482713	4	PRAD	54.03	YES	YES	YES	No	70	White	Tumor	1	619	Male	54.03	Matched	NA	Alive	Prostate	4.436621202	25
prad_mcspc_mskcc_2020	P-0001202	P-0001202-T01-IM3	71	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.0271	IMPACT341	MSKCC	Yes	NA	0	Stable	745602	3	PRAD	7.73	YES	NO	YES	No	565	White	Tumor	1	572	Male	3.74	Matched	NA	Dead	Prostate	3.327465902	60
prad_mcspc_mskcc_2020	P-0001204	P-0001204-T01-IM3	56	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.0376	IMPACT341	MSKCC	Yes	NA	0.08	Stable	745655	2	PRAD	35.68	YES	YES	YES	No	5	White	Tumor	1	1130	Male	13.77	Matched	NA	Dead	Prostate	2.218310601	15
prad_mcspc_mskcc_2020	P-0001206	P-0001206-T01-IM3	61	No	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.3180	IMPACT341	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.93	Stable	745727	NA	PRAD	61.37	YES	YES	YES	No	84	Black or African American	Tumor	1	849	Male	16.39	Matched	NA	Dead	Prostate	0	25
prad_mcspc_mskcc_2020	P-0001221	P-0001221-T01-IM3	52	Yes	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1324	IMPACT341	MSKCC	Yes	NA	0.41	Stable	745966	NA	PRAD	109.57	YES	YES	YES	No	11	White	Tumor	1	543	Male	26.61	Matched	NA	Dead	Prostate	0	40
prad_mcspc_mskcc_2020	P-0001230	P-0001230-T01-IM3	64	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.1945	IMPACT341	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.25	Stable	482641	3	PRAD	57.71	YES	YES	YES	No	21	White	Tumor	1	515	Male	20.7	Matched	NA	Alive	Bone	3.327465902	30
prad_mcspc_mskcc_2020	P-0001242	P-0001242-T01-IM3	<45	Yes	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.1600	IMPACT341	MSKCC	Yes	NA	0.09	Stable	745861	1	PRAD	62.03	YES	YES	YES	No	6	White	Tumor	1	543	Male	13.74	Matched	NA	Alive	Prostate	1.109155301	40
prad_mcspc_mskcc_2020	P-0001244	P-0001244-T02-IM3	62	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.2922	IMPACT341	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.42	Stable	760793	1	PRAD	115.37	YES	YES	YES	No	5	White	Tumor	1	586	Male	115.37	Matched	NA	Alive	Prostate	1.109155301	20
prad_mcspc_mskcc_2020	P-0001319	P-0001319-T03-IM5	50	Yes	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0523	IMPACT410	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	NA	3	PRAD	19.37	YES	YES	NO	No	2	White	Tumor	1	506	Male	5.19	Matched	NA	Dead	Prostate	2.936159093	30
prad_mcspc_mskcc_2020	P-0001332	P-0001332-T01-IM3	50	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0509	IMPACT341	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.2	Stable	NA	1	PRAD	52.53	YES	YES	NO	No	6	Other	Tumor	1	816	Male	51.52	Matched	NAAdded back GNAS, DIS3, EPHB1, PTPRTNA	Alive	Prostate	1.109155301	NA
prad_mcspc_mskcc_2020	P-0001407	P-0001407-T01-IM3	57	Yes	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.1911	IMPACT341	MSKCC	Yes	NA	1.35	Stable	754660	2	PRAD	76.93	YES	YES	YES	No	19	White	Tumor	1	461	Male	16.1	Matched	NA	Dead	Prostate	2.218310601	15
prad_mcspc_mskcc_2020	P-0001426	P-0001426-T01-IM3	70	No	NO	NA	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.3625	IMPACT341	MSKCC	No	NA	0.95	Stable	NA	12	PRAD	27.17	YES	NO	NO	No	NA	White	Tumor	1	829	Male	3.23	Matched	NA	Dead	Lymph Node	13.30986361	70
prad_mcspc_mskcc_2020	P-0001449	P-0001449-T01-IM3	57	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1125	IMPACT341	MSKCC	Yes	NA	0	Stable	754987	3	PRAD	27.97	YES	YES	YES	No	510	White	Tumor	1	351	Male	6.87	Matched	NA	Dead	Prostate	3.327465902	30
prad_mcspc_mskcc_2020	P-0001462	P-0001462-T01-IM3	53	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.2112	IMPACT341	MSKCC	No	NA	2.11	Stable	754519	3	PRAD	48.27	YES	NO	YES	No	7	White	Tumor	1	392	Male	44.39	Matched	NA	Alive	Prostate	3.327465902	30
prad_mcspc_mskcc_2020	P-0001684	P-0001684-T01-IM3	66	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.1506	IMPACT341	MSKCC	No	NA	0.27	Stable	761041	1	PRAD	48.6	YES	YES	YES	No	3	White	Tumor	1	194	Male	48.13	Matched	NA	Alive	Bone	1.109155301	20
prad_mcspc_mskcc_2020	P-0001687	P-0001687-T01-IM3	63	Yes	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.3868	IMPACT341	MSKCC	Yes	NA	0.08	Stable	761055	6	PRAD	36.1	YES	NO	YES	No	36	White	Tumor	1	665	Male	2.17	Matched	NA	Dead	Bone	6.654931804	40
prad_mcspc_mskcc_2020	P-0001768	P-0001768-T01-IM3	53	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.1374	IMPACT341	MSKCC	Yes	NA	0.66	Stable	760687	2	PRAD	42.18	YES	YES	YES	No	277	White	Tumor	1	376	Male	17.68	Matched	NA	Dead	Prostate	2.218310601	40
prad_mcspc_mskcc_2020	P-0001774	P-0001774-T01-IM3	74	Yes	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.0919	IMPACT341	MSKCC	Yes	NA	23.72	Instable	482702	45	PRAD	50.55	YES	YES	YES	No	6	White	Tumor	1	583	Male	50.55	Matched	NA	Alive	Prostate	49.91198853	60
prad_mcspc_mskcc_2020	P-0001829	P-0001829-T02-IM5	73	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.1381	IMPACT410	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.14	Stable	425117	4	PRAD	28.97	YES	YES	YES	No	10	White	Tumor	1	1161	Male	8.19	Matched	NA	Alive	Bone	3.91487879	15
prad_mcspc_mskcc_2020	P-0001845	P-0001845-T01-IM3	48	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.1732	IMPACT341	MSKCC	No	NA	0.11	Stable	760935	3	PRAD	33.55	YES	NO	YES	No	8	White	Tumor	1	418	Male	18.19	Matched	NA	Alive	Prostate	3.327465902	15
prad_mcspc_mskcc_2020	P-0001876	P-0001876-T01-IM3	66	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.0213	IMPACT341	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	751054	NA	PRAD	82.53	YES	YES	YES	No	8	White	Tumor	1	678	Male	78.87	Matched	NA	Alive	Prostate	0	15
prad_mcspc_mskcc_2020	P-0002101	P-0002101-T01-IM3	56	Yes	NO	3+4	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0353	IMPACT341	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	2.29	Stable	747593	NA	PRAD	126.87	YES	NO	YES	No	24	White	Tumor	1	136	Male	80.84	Matched	NA	Dead	Prostate	0	20
prad_mcspc_mskcc_2020	P-0002123	P-0002123-T02-IM5	60	No	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.1035	IMPACT410	MSKCC	No	NA	0.45	Stable	NA	3	PRAD	33.13	YES	YES	NO	No	4	Other	Tumor	1	1031	Male	33.13	Matched	NA	Alive	Lymph Node	2.936159093	20
prad_mcspc_mskcc_2020	P-0002196	P-0002196-T01-IM3	65	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0041	IMPACT341	MSKCC	Yes	NA	0.1	Stable	739626	3	PRAD	54.53	YES	NO	YES	No	17	White	Tumor	1	971	Male	18.43	Matched	NA	Dead	Prostate	3.327465902	50
prad_mcspc_mskcc_2020	P-0002334	P-0002334-T02-IM6	81	No	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.1819	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.52	Stable	748899	4	PRAD	9.65	YES	YES	YES	No	5	White	Tumor	1	816	Male	9.65	Matched	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 8q.	Alive	Other soft tissue	3.45879238	60
prad_mcspc_mskcc_2020	P-0002375	P-0002375-T02-IM6	67	No	NO	<7	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.1190	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.05	Stable	1059990	8	PRAD	4.39	YES	YES	YES	No	8	White	Tumor	1	699	Male	4.26	Matched	NA	Alive	Other soft tissue	6.91758476	20
prad_mcspc_mskcc_2020	P-0002431	P-0002431-T02-IM6	68	No	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0005	IMPACT468	MSKCC	No	NA	0	Do not report	558157	2	PRAD	20.47	YES	YES	YES	No	24	NA	Tumor	1	717	Male	20.47	Matched	NA	Alive	Bone	1.72939619	20
prad_mcspc_mskcc_2020	P-0002499	P-0002499-T01-IM3	51	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0026	IMPACT341	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.07	Stable	735661	3	PRAD	46.07	YES	YES	YES	No	67	White	Tumor	1	646	Male	40.39	Matched	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	Alive	Prostate	3.327465902	NA
prad_mcspc_mskcc_2020	P-0002612	P-0002612-T01-IM3	58	No	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.1063	IMPACT341	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	735602	NA	PRAD	48.1	YES	YES	YES	No	12	White	Tumor	1	511	Male	11	Matched	NA	Dead	Lymph Node	0	NA
prad_mcspc_mskcc_2020	P-0002898	P-0002898-T02-IM5	63	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.2005	IMPACT410	MSKCC	Yes	NA	0.23	Stable	NA	6	PRAD	54.8	YES	YES	NO	No	17	White	Tumor	1	576	Male	24.81	Matched	NANote: Copy number profile is suggestive of broad copy number loss on Chromosome arms 16q, 17p and 18q      Note: The EPHA7 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested,	Alive	Lymph Node	5.872318186	80
prad_mcspc_mskcc_2020	P-0002974	P-0002974-T02-IM6	71	No	NO	<7	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.1471	IMPACT468	MSKCC	No	NA	0.6	Do not report	526294	2	PRAD	26.63	YES	YES	YES	No	6	White	Tumor	1	905	Male	26.3	Matched	NA	Alive	Prostate	1.72939619	40
prad_mcspc_mskcc_2020	P-0003033	P-0003033-T01-IM5	57	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.2654	IMPACT410	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.35	Stable	NA	3	PRAD	7.93	YES	NO	NO	No	49	White	Tumor	1	562	Male	6.1	Matched	NANote: The CCND1, FGF19, FGF3 and FGF4 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.NA	Dead	Prostate	2.936159093	30
prad_mcspc_mskcc_2020	P-0003061	P-0003061-T02-IM6	64	No	NO	3+4	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.0748	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	984332	1	PRAD	7.94	YES	YES	YES	No	18	White	Tumor	1	685	Male	7.94	Matched	NA	Alive	Prostate	0.864698095	30
prad_mcspc_mskcc_2020	P-0003150	P-0003150-T01-IM5	64	No	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.3933	IMPACT410	MSKCC	Yes	NA	0.41	Stable	NA	2	PRAD	74.27	YES	YES	NO	No	2	White	Tumor	1	221	Male	55.75	Matched	NA	Alive	Lung	1.957439395	60
prad_mcspc_mskcc_2020	P-0003395	P-0003395-T01-IM5	74	Yes	NO	3+4	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.5793	IMPACT410	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.66	Stable	NA	2	PRAD	23.29	YES	NO	NO	No	13	NA	Tumor	1	441	Male	11.13	Matched	NA	Dead	Bone	1.957439395	30
prad_mcspc_mskcc_2020	P-0003506	P-0003506-T01-IM5	67	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.1928	IMPACT410	MSKCC	Yes	NA	0.16	Stable	NA	2	PRAD	44.77	YES	NO	NO	No	14	White	Tumor	1	521	Male	23.19	Matched	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q.	Dead	Prostate	1.957439395	50
prad_mcspc_mskcc_2020	P-0003519	P-0003519-T01-IM5	51	Yes	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1061	IMPACT410	MSKCC	Yes	NA	0.09	Stable	NA	2	PRAD	56.65	YES	YES	NO	No	539	White	Tumor	1	409	Male	8.29	Matched	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	Dead	Prostate	1.957439395	10
prad_mcspc_mskcc_2020	P-0003538	P-0003538-T01-IM5	65	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.2501	IMPACT410	MSKCC	Yes	NA	0.75	Stable	NA	3	PRAD	22.13	YES	NO	NO	No	149	White	Tumor	1	632	Male	7.26	Matched	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	Dead	Prostate	2.936159093	60
prad_mcspc_mskcc_2020	P-0003616	P-0003616-T01-IM5	73	No	NO	NA	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.0519	IMPACT410	MSKCC	Yes	NA	0.78	Stable	NA	4	PRAD	35.73	YES	NO	NO	No	4	White	Tumor	1	142	Male	17.48	Matched	NA	Dead	Lymph Node	3.91487879	60
prad_mcspc_mskcc_2020	P-0003684	P-0003684-T01-IM5	63	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.0139	IMPACT410	MSKCC	Yes	NA	0	Stable	NA	NA	PRAD	30.71	YES	YES	NO	No	21	White	Tumor	1	566	Male	12.68	Matched	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	Dead	Prostate	0	20
prad_mcspc_mskcc_2020	P-0003741	P-0003741-T01-IM5	65	Yes	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.1676	IMPACT410	MSKCC	Yes	NA	0	Stable	NA	2	PRAD	80.03	YES	NO	NO	No	30	White	Tumor	1	231	Male	4.4	Matched	NA	Alive	Prostate	1.957439395	30
prad_mcspc_mskcc_2020	P-0003799	P-0003799-T01-IM5	56	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0747	IMPACT410	MSKCC	Yes	NA	0	Stable	NA	2	PRAD	53.62	YES	NO	NO	No	26	White	Tumor	1	510	Male	10.39	Matched	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	Dead	Prostate	1.957439395	20
prad_mcspc_mskcc_2020	P-0003852	P-0003852-T01-IM5	52	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1820	IMPACT410	MSKCC	Yes	NA	0	Stable	482691	3	PRAD	56.13	YES	YES	YES	No	475	White	Tumor	1	541	Male	3.14	Matched	NANote: The EZH2 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.NA	Alive	Prostate	2.936159093	30
prad_mcspc_mskcc_2020	P-0003856	P-0003856-T01-IM5	56	No	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1647	IMPACT410	MSKCC	Yes	NA	0	Stable	NA	1	PRAD	23.23	YES	NO	NO	No	80	White	Tumor	1	329	Male	1.71	Matched	NANote: The NBN copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.NA	Dead	Liver	0.978719698	70
prad_mcspc_mskcc_2020	P-0003939	P-0003939-T01-IM3	63	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.0033	IMPACT341	MSKCC	Yes	NA	0.08	Stable	473354	3	PRAD	63.4	YES	YES	YES	No	31	White	Tumor	1	894	Male	15.3	Matched	NA	Alive	Prostate	3.327465902	60
prad_mcspc_mskcc_2020	P-0004285	P-0004285-T01-IM5	58	Yes	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0000	IMPACT410	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	NA	5	PRAD	47.64	YES	YES	NO	No	50	NA	Tumor	1	471	Male	42.17	Matched	NA	Alive	Lymph Node	4.893598488	60
prad_mcspc_mskcc_2020	P-0004526	P-0004526-T01-IM5	74	Yes	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0103	IMPACT410	MSKCC	Yes	NA	0	Stable	482686	2	PRAD	73.37	YES	YES	YES	No	28	White	Tumor	1	718	Male	48.13	Matched	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	Alive	Prostate	1.957439395	30
prad_mcspc_mskcc_2020	P-0004538	P-0004538-T01-IM5	80	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.0671	IMPACT410	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	482712	1	PRAD	55.57	YES	NO	YES	No	33	NA	Tumor	1	698	Male	12.47	Matched	NA	Dead	Prostate	0.978719698	30
prad_mcspc_mskcc_2020	P-0004597	P-0004597-T02-IM5	74	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.2189	IMPACT410	MSKCC	No	NA	0.08	Stable	NA	3	PRAD	53.63	YES	NO	NO	No	5	White	Tumor	1	775	Male	51.67	Matched	NA	Dead	Prostate	2.936159093	20
prad_mcspc_mskcc_2020	P-0004892	P-0004892-T01-IM5	66	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.1608	IMPACT410	MSKCC	Yes	NA	0.07	Stable	NA	12	PRAD	40.67	YES	YES	NO	No	5	White	Tumor	1	904	Male	25.5	Matched	Note: The MLL3 exon36 mutations all occur in cis (same allele).	Alive	Lung	11.74463637	40
prad_mcspc_mskcc_2020	P-0005045	P-0005045-T01-IM5	67	Yes	NO	3+4	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.1616	IMPACT410	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	2	Stable	NA	1	PRAD	108.07	YES	YES	NO	No	6	White	Tumor	1	412	Male	2.33	Matched	NANote: The PIK3C2G copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.NA	Alive	Lymph Node	0.978719698	70
prad_mcspc_mskcc_2020	P-0005050	P-0005050-T01-IM5	65	No	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.1777	IMPACT410	MSKCC	No	NA	1.06	Stable	482666	3	PRAD	60.26	YES	NO	YES	No	3	White	Tumor	1	802	Male	60.26	Matched	NA	Alive	Lymph Node	2.936159093	80
prad_mcspc_mskcc_2020	P-0005098	P-0005098-T01-IM5	49	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0930	IMPACT410	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	1	Stable	NA	1	PRAD	51.5	YES	YES	NO	No	6	NA	Tumor	1	422	Male	18.43	Matched	NA	Alive	Prostate	0.978719698	30
prad_mcspc_mskcc_2020	P-0005111	P-0005111-T01-IM5	62	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.0038	IMPACT410	MSKCC	Yes	NA	2.15	Stable	NA	5	PRAD	46.55	YES	NO	NO	No	672	NA	Tumor	1	566	Male	12.45	Matched	NA	Alive	Lymph Node	4.893598488	30
prad_mcspc_mskcc_2020	P-0005213	P-0005213-T02-IM6	71	Yes	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.0429	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	745243	4	PRAD	10.32	YES	YES	YES	No	3	White	Tumor	1	380	Male	0.17	Matched	NANote: Low tumor content (approximately 20% or less).  Negative structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution. Additional mutations and copy number changes may not be detected due to low tumor co	Alive	Bone	3.45879238	10
prad_mcspc_mskcc_2020	P-0005217	P-0005217-T03-IM5	54	Yes	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.2083	IMPACT410	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.13	Stable	NA	2	PRAD	80.07	YES	YES	NO	No	41	White	Tumor	1	855	Male	70.84	Matched	NANote: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.NA	Alive	Prostate	1.957439395	10
prad_mcspc_mskcc_2020	P-0005436	P-0005436-T02-IM5	65	No	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.1117	IMPACT410	MSKCC	No	NA	0.23	Stable	427767	3	PRAD	28.87	YES	YES	YES	No	5	White	Tumor	1	1079	Male	29.2	Matched	NA	Alive	Lymph Node	2.936159093	80
prad_mcspc_mskcc_2020	P-0005454	P-0005454-T01-IM5	61	Yes	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.2443	IMPACT410	MSKCC	Yes	NA	0.7	Stable	NA	2	PRAD	30.45	YES	YES	NO	No	5	White	Tumor	1	967	Male	1.39	Matched	NANote: The MYC,  NBN, RAD21 and FAT1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.NA	Dead	Lymph Node	1.957439395	60
prad_mcspc_mskcc_2020	P-0005535	P-0005535-T01-IM5	61	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.3278	IMPACT410	MSKCC	Yes	NA	0.31	Stable	NA	6	PRAD	50.58	YES	NO	NO	No	16	White	Tumor	1	910	Male	10.29	Matched	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.     Note: The CDKN1B exon 1 mutations all occur in cis (same allele	Alive	Prostate	5.872318186	50
prad_mcspc_mskcc_2020	P-0005571	P-0005571-T01-IM5	56	No	NO	3+4	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.5060	IMPACT410	MSKCC	No	NA	0.18	Stable	NA	1	PRAD	3.4	YES	NO	NO	No	7	White	Tumor	1	291	Male	2.87	Matched	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Negative results should be interpreted with caution.	Alive	Lymph Node	0.978719698	60
prad_mcspc_mskcc_2020	P-0005639	P-0005639-T01-IM5	61	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1247	IMPACT410	MSKCC	Yes	NA	0.68	Stable	NA	4	PRAD	11	YES	NO	NO	No	471	White	Tumor	1	346	Male	3.04	Matched	NA	Dead	Prostate	4.893598488	30
prad_mcspc_mskcc_2020	P-0005649	P-0005649-T01-IM5	54	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.3842	IMPACT410	MSKCC	No	NA	0.43	Stable	NA	NA	PRAD	20.43	YES	NO	NO	No	14	White	Tumor	1	627	Male	1.47	Matched	NANote: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.NA	Dead	Prostate	0	10
prad_mcspc_mskcc_2020	P-0005698	P-0005698-T01-IM5	77	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1219	IMPACT410	MSKCC	No	NA	0.3	Stable	NA	1	PRAD	2.86	YES	NO	NO	No	495	White	Tumor	1	687	Male	2.41	Matched	NA	Alive	Prostate	0.978719698	30
prad_mcspc_mskcc_2020	P-0005713	P-0005713-T01-IM5	80	Yes	NO	3+4	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.1993	IMPACT410	MSKCC	Yes	NA	0.24	Stable	NA	4	PRAD	37.65	YES	YES	NO	No	4	White	Tumor	1	324	Male	24.07	Matched	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	Alive	Lung	3.91487879	80
prad_mcspc_mskcc_2020	P-0005774	P-0005774-T01-IM5	55	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1917	IMPACT410	MSKCC	Yes	NA	0	Stable	NA	3	PRAD	31.52	YES	YES	NO	No	20	Black or African American	Tumor	1	475	Male	11.83	Matched	NA	Dead	Prostate	2.936159093	20
prad_mcspc_mskcc_2020	P-0005804	P-0005804-T01-IM5	66	No	NO	NA	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0964	IMPACT410	MSKCC	No	NA	0.08	Stable	482755	2	PRAD	38.94	YES	YES	YES	No	12	White	Tumor	1	699	Male	38.81	Matched	NA	Alive	Prostate	1.957439395	60
prad_mcspc_mskcc_2020	P-0005810	P-0005810-T01-IM5	74	No	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.0978	IMPACT410	MSKCC	No	NA	0.14	Stable	482654	2	PRAD	59.84	YES	YES	YES	No	5	White	Tumor	1	974	Male	58.67	Matched	NA	Alive	Lymph Node	1.957439395	30
prad_mcspc_mskcc_2020	P-0005890	P-0005890-T01-IM5	75	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.0171	IMPACT410	MSKCC	Yes	NA	0	Stable	NA	1	PRAD	20.45	YES	YES	NO	No	7	White	Tumor	1	723	Male	7.1	Matched	NANote: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.NA	Dead	Bone	0.978719698	20
prad_mcspc_mskcc_2020	P-0005933	P-0005933-T01-IM5	70	Yes	NO	8	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.3343	IMPACT410	MSKCC	Yes	NA	0.43	Stable	NA	1	PRAD	21.81	YES	YES	NO	No	11	White	Tumor	1	836	Male	0.7	Matched	NANote: The APC and RASA1 copy number losses fall slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically indicated.      Note: The ZRSR2 and EIF1AX copy number gains fall slightly below th	Alive	Lymph Node	0.978719698	70
prad_mcspc_mskcc_2020	P-0005953	P-0005953-T03-IM6	53	No	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0165	IMPACT468	MSKCC	Yes	NA	0.08	Do not report	509910	4	PRAD	22.63	YES	YES	YES	No	8	White	Tumor	1	552	Male	4.87	Matched	NA	Dead	Prostate	3.45879238	20
prad_mcspc_mskcc_2020	P-0006029	P-0006029-T01-IM5	75	Yes	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.0035	IMPACT410	MSKCC	No	NA	0.09	Stable	NA	7	PRAD	0.29	YES	NO	NO	No	6	NA	Tumor	1	713	Male	0	Matched	NA	Alive	Bone	6.851037883	60
prad_mcspc_mskcc_2020	P-0006057	P-0006057-T01-IM5	51	Yes	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.0035	IMPACT410	MSKCC	No	NA	0	Stable	NA	2	PRAD	32.48	YES	YES	NO	No	10	White	Tumor	1	872	Male	32.48	Matched	NANote: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.NA	Alive	Prostate	1.957439395	20
prad_mcspc_mskcc_2020	P-0006108	P-0006108-T02-IM5	51	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0214	IMPACT410	MSKCC	Yes	NA	0.09	Stable	NA	2	PRAD	46.23	YES	YES	NO	No	459	White	Tumor	1	691	Male	6.84	Matched	NANote: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.NA	Alive	Prostate	1.957439395	15
prad_mcspc_mskcc_2020	P-0006226	P-0006226-T02-IM5	72	No	NO	3+4	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.3145	IMPACT410	MSKCC	No	NA	0.26	Stable	NA	10	PRAD	9.16	YES	NO	NO	No	4	White	Tumor	1	864	Male	0	Matched	NA	Dead	Other soft tissue	9.787196976	70
prad_mcspc_mskcc_2020	P-0006595	P-0006595-T01-IM5	65	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.2122	IMPACT410	MSKCC	Yes	NA	1.43	Stable	NA	7	PRAD	32	YES	YES	NO	No	510	NA	Tumor	1	1175	Male	12.74	Matched	NANote: Copy number profile is suggestive of broad copy number gain on Chromosome arms of 13q and 16q.      Note: The ERBB4 copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, 	Alive	Prostate	6.851037883	70
prad_mcspc_mskcc_2020	P-0006602	P-0006602-T02-IM5	66	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.1115	IMPACT410	MSKCC	No	NA	0.24	Stable	NA	4	PRAD	64.57	YES	YES	NO	No	14	White	Tumor	1	199	Male	64.57	Matched	NA	Alive	Other soft tissue	3.91487879	30
prad_mcspc_mskcc_2020	P-0006603	P-0006603-T01-IM5	61	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.4375	IMPACT410	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	3	Stable	NA	1	PRAD	37	YES	NO	NO	No	14	NA	Tumor	1	658	Male	37	Matched	NA	Alive	Lymph Node	0.978719698	NA
prad_mcspc_mskcc_2020	P-0006619	P-0006619-T01-IM5	48	Yes	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0	IMPACT410	MSKCC	No	NA	0.14	Stable	NA	2	PRAD	37.57	YES	YES	NO	No	67	White	Tumor	1	1047	Male	37.57	Matched	NA	Alive	Prostate	1.957439395	30
prad_mcspc_mskcc_2020	P-0006692	P-0006692-T01-IM5	68	Yes	NO	NA	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.6225	IMPACT410	MSKCC	Yes	NA	0.88	Stable	482655	6	PRAD	30.32	YES	NO	YES	No	12	White	Tumor	1	831	Male	0.2	Matched	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 20q12 and 20q13	Alive	Other soft tissue	5.872318186	70
prad_mcspc_mskcc_2020	P-0006751	P-0006751-T01-IM5	74	No	NO	NA	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.2454	IMPACT410	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.28	Stable	NA	1	PRAD	49.65	YES	NO	NO	No	NA	White	Tumor	1	879	Male	34.47	Matched	NA	Alive	Other soft tissue	0.978719698	70
prad_mcspc_mskcc_2020	P-0006815	P-0006815-T01-IM5	56	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1117	IMPACT410	MSKCC	Yes	NA	0.19	Stable	NA	2	PRAD	53.67	YES	YES	NO	No	26	White	Tumor	1	413	Male	22.57	Matched	NA	Alive	Prostate	1.957439395	60
prad_mcspc_mskcc_2020	P-0006894	P-0006894-T01-IM5	60	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.1040	IMPACT410	MSKCC	No	NA	0.16	Stable	NA	2	PRAD	36.37	YES	YES	NO	No	14	NA	Tumor	1	406	Male	35.16	Matched	NANote: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.NA	Alive	Other soft tissue	1.957439395	10
prad_mcspc_mskcc_2020	P-0006931	P-0006931-T01-IM5	54	Yes	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.0932	IMPACT410	MSKCC	Yes	NA	0.07	Stable	NA	1	PRAD	35.13	YES	NO	NO	No	28	White	Tumor	1	650	Male	26.93	Matched	NANote: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.NA	Alive	Lymph Node	0.978719698	20
prad_mcspc_mskcc_2020	P-0006997	P-0006997-T01-IM5	55	No	NO	3+4	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.0810	IMPACT410	MSKCC	Yes	NA	0.33	Stable	NA	2	PRAD	40.84	YES	YES	NO	No	211	White	Tumor	1	537	Male	13.5	Matched	NA	Alive	Prostate	1.957439395	20
prad_mcspc_mskcc_2020	P-0007025	P-0007025-T01-IM5	62	No	NO	NA	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.2490	IMPACT410	MSKCC	Yes	NA	0.3	Stable	NA	2	PRAD	46.83	YES	YES	NO	No	27	White	Tumor	1	981	Male	16.03	Matched	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arms of 10q21 and 17p12-13   Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms of 5q32 and  5q35	Alive	Lymph Node	1.957439395	10
prad_mcspc_mskcc_2020	P-0007043	P-0007043-T01-IM5	84	No	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.2194	IMPACT410	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.29	Stable	NA	3	PRAD	37.84	YES	YES	NO	No	9	White	Tumor	1	470	Male	4.97	Matched	NA	Dead	Bone	2.936159093	30
prad_mcspc_mskcc_2020	P-0007137	P-0007137-T01-IM5	65	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.0789	IMPACT410	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.08	Stable	NA	2	PRAD	117.68	YES	YES	NO	No	11330	White	Tumor	1	788	Male	11.16	Matched	NANote: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.NA	Alive	Prostate	1.957439395	10
prad_mcspc_mskcc_2020	P-0007139	P-0007139-T01-IM5	59	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.3070	IMPACT410	MSKCC	No	NA	0.51	Stable	NA	2	PRAD	41.06	YES	YES	NO	No	15	White	Tumor	1	1049	Male	41.06	Matched	NA	Alive	Prostate	1.957439395	70
prad_mcspc_mskcc_2020	P-0007143	P-0007143-T01-IM5	69	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.2706	IMPACT410	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.14	Stable	NA	NA	PRAD	20	YES	NO	NO	No	44	White	Tumor	1	756	Male	8.29	Matched	Note: Assessment of the copy number profile is somewhat limited by increased background noise.  Confirmation of copy number gain by alternate methods is suggested if clinically indicated.	Dead	Prostate	0	50
prad_mcspc_mskcc_2020	P-0007182	P-0007182-T01-IM5	81	Yes	NO	3+4	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.6109	IMPACT410	MSKCC	Yes	NA	0.97	Stable	NA	3	PRAD	21.42	YES	YES	NO	No	14	White	Tumor	1	387	Male	11	Matched	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm of 8q      Note: Copy number profile is suggestive of broad copy number loss on Chromosome  arm of 17p	Alive	Bone	2.936159093	70
prad_mcspc_mskcc_2020	P-0007219	P-0007219-T01-IM5	64	No	NO	3+4	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.0289	IMPACT410	MSKCC	Yes	NA	0	Stable	NA	1	PRAD	38.16	YES	YES	NO	No	3	White	Tumor	1	757	Male	16.55	Matched	NANote: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.NA	Dead	Lymph Node	0.978719698	15
prad_mcspc_mskcc_2020	P-0007267	P-0007267-T01-IM5	69	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.1479	IMPACT410	MSKCC	Yes	NA	0.41	Stable	NA	2	PRAD	50.1	YES	YES	NO	No	10	White	Tumor	1	874	Male	14.23	Matched	NA	Alive	Prostate	1.957439395	60
prad_mcspc_mskcc_2020	P-0007313	P-0007313-T01-IM5	76	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.2791	IMPACT410	MSKCC	Yes	NA	0.41	Stable	NA	2	PRAD	31.07	YES	NO	NO	No	6	White	Tumor	1	624	Male	20.84	Matched	NANote: A comparison of variant frequencies suggests the IRF4 p.C255Y mutation is subclonal.     Note: The HGF copy number loss falls slightly below the cut off criteria for deletion. Confirmatory testing by an alternate method is suggested, if clinically	Alive	Prostate	1.957439395	80
prad_mcspc_mskcc_2020	P-0007332	P-0007332-T01-IM5	68	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.0570	IMPACT410	MSKCC	Yes	NA	0	Stable	NA	2	PRAD	28	YES	YES	NO	No	28	White	Tumor	1	231	Male	13.67	Matched	NA	Dead	Prostate	1.957439395	50
prad_mcspc_mskcc_2020	P-0007359	P-0007359-T01-IM5	60	Yes	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0006	IMPACT410	MSKCC	Yes	NA	0	Stable	NA	1	PRAD	75.87	YES	YES	NO	No	110	White	Tumor	1	570	Male	46.13	Matched	NANote: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.NA	Alive	Prostate	0.978719698	40
prad_mcspc_mskcc_2020	P-0007402	P-0007402-T01-IM5	60	No	NO	NA	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1920	IMPACT410	MSKCC	No	NA	0.17	Stable	482662	3	PRAD	33.87	YES	YES	YES	No	10000	White	Tumor	1	763	Male	33.87	Matched	NA	Alive	Lymph Node	2.936159093	25
prad_mcspc_mskcc_2020	P-0007547	P-0007547-T01-IM5	73	Yes	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.3682	IMPACT410	MSKCC	Yes	NA	0.62	Stable	NA	1	PRAD	22.27	YES	NO	NO	No	2	White	Tumor	1	674	Male	0.65	Matched	NA	Dead	Lung	0.978719698	80
prad_mcspc_mskcc_2020	P-0007629	P-0007629-T01-IM5	70	Yes	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.2669	IMPACT410	MSKCC	Yes	NA	0.45	Stable	482652	4	PRAD	44.7	YES	YES	YES	No	14	White	Tumor	1	455	Male	9.03	Matched	NA	Alive	Bone	3.91487879	20
prad_mcspc_mskcc_2020	P-0007647	P-0007647-T01-IM5	49	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.1106	IMPACT410	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.85	Stable	NA	NA	PRAD	19.65	YES	YES	NO	No	21	White	Tumor	1	875	Male	8.03	Matched	NA	Dead	Lymph Node	0	NA
prad_mcspc_mskcc_2020	P-0007734	P-0007734-T01-IM5	72	Yes	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.4614	IMPACT410	MSKCC	No	NA	1.42	Stable	NA	3	PRAD	87.35	YES	YES	NO	No	3	NA	Tumor	1	131	Male	87.35	Matched	NA	Alive	Liver	2.936159093	80
prad_mcspc_mskcc_2020	P-0007749	P-0007749-T01-IM5	61	No	NO	NA	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.2429	IMPACT410	MSKCC	Yes	NA	0.38	Stable	NA	2	PRAD	11.19	YES	NO	NO	No	1001	White	Tumor	1	884	Male	4.13	Matched	NA	Alive	Other soft tissue	1.957439395	40
prad_mcspc_mskcc_2020	P-0007930	P-0007930-T02-IM5	48	No	NO	<7	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.0263	IMPACT410	MSKCC	No	NA	0.08	Stable	414478	3	PRAD	30.55	YES	YES	YES	No	7	White	Tumor	1	658	Male	30.55	Matched	NA	Alive	Lymph Node	2.936159093	20
prad_mcspc_mskcc_2020	P-0008069	P-0008069-T01-IM5	65	No	NO	NA	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.0028	IMPACT410	MSKCC	No	NA	0.08	Stable	NA	1	PRAD	5.58	YES	NO	NO	No	1	White	Tumor	1	895	Male	5.58	Matched	NANote: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.NA	Dead	Liver	0.978719698	15
prad_mcspc_mskcc_2020	P-0008077	P-0008077-T02-IM5	78	NA	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.1323	IMPACT410	MSKCC	No	NA	0.62	Stable	NA	7	PRAD	100	YES	YES	NO	No	NA	Black or African American	Tumor	1	303	Male	91.27	Matched	NA	Dead	Lung	6.851037883	65
prad_mcspc_mskcc_2020	P-0008098	P-0008098-T01-IM5	68	Yes	NO	3+4	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.2853	IMPACT410	MSKCC	Yes	NA	0.47	Stable	482646	5	PRAD	21.58	YES	YES	YES	No	6	White	Tumor	1	882	Male	0.43	Matched	Note: The copy number profile is suggestive of an intragenic gain of MLL3 exons 1-42 and 47-59.	Dead	Bone	4.893598488	20
prad_mcspc_mskcc_2020	P-0008139	P-0008139-T03-IM5	69	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.2178	IMPACT410	MSKCC	Yes	NA	0.85	Do not report	473743	4	PRAD	49.32	YES	YES	YES	No	NA	NA	Tumor	1	781	Male	20.57	Matched	NA	Alive	Prostate	3.91487879	50
prad_mcspc_mskcc_2020	P-0008235	P-0008235-T01-IM5	77	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0709	IMPACT410	MSKCC	Yes	NA	0.08	Stable	NA	6	PRAD	48.52	YES	YES	NO	No	155	White	Tumor	1	788	Male	11	Matched	NA	Alive	Prostate	5.872318186	35
prad_mcspc_mskcc_2020	P-0008301	P-0008301-T01-IM5	59	No	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.0344	IMPACT410	MSKCC	No	NA	0.16	Stable	NA	4	PRAD	34.03	YES	YES	NO	No	11	White	Tumor	1	916	Male	33.23	Matched	NANote: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.NA	Alive	Bone	2.936159093	10
prad_mcspc_mskcc_2020	P-0008330	P-0008330-T01-IM5	64	No	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.3141	IMPACT410	MSKCC	No	NA	0.37	Stable	NA	2	PRAD	32.94	YES	YES	NO	No	11	White	Tumor	1	961	Male	6.29	Matched	NA	Alive	Lung	1.957439395	60
prad_mcspc_mskcc_2020	P-0008339	P-0008339-T01-IM5	63	No	NO	<7	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.0159	IMPACT410	MSKCC	Yes	NA	0	Stable	NA	2	PRAD	160.53	YES	YES	NO	No	5	White	Tumor	1	505	Male	127.68	Matched	NANote: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.NA	Alive	Bone	1.957439395	10
prad_mcspc_mskcc_2020	P-0008383	P-0008383-T01-IM5	54	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.0032	IMPACT410	MSKCC	No	NA	0.37	Stable	NA	1	PRAD	33.39	YES	YES	NO	No	292	NA	Tumor	1	878	Male	33.39	Matched	NANote: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.NA	Alive	Lymph Node	0.978719698	10
prad_mcspc_mskcc_2020	P-0008470	P-0008470-T01-IM5	72	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.3385	IMPACT410	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.84	Stable	NA	4	PRAD	39.93	YES	YES	NO	No	69	NA	Tumor	1	441	Male	3.96	Matched	NA	Dead	Prostate	3.91487879	80
prad_mcspc_mskcc_2020	P-0008542	P-0008542-T01-IM5	83	No	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.2684	IMPACT410	MSKCC	Yes	NA	0.08	Stable	NA	NA	PRAD	45.87	YES	YES	NO	No	6	White	Tumor	1	1108	Male	29.77	Matched	NANote: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.NA	Alive	Lymph Node	0	10
prad_mcspc_mskcc_2020	P-0008661	P-0008661-T01-IM5	54	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.1200	IMPACT410	MSKCC	Yes	NA	0.18	Stable	NA	4	PRAD	44.37	YES	YES	NO	No	9	White	Tumor	1	854	Male	44.37	Matched	NA	Alive	Prostate	3.91487879	40
prad_mcspc_mskcc_2020	P-0008682	P-0008682-T01-IM5	49	No	NO	NA	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0628	IMPACT410	MSKCC	Yes	NA	11.14	Instable	NA	26	PRAD	37.81	YES	YES	NO	No	199	NA	Tumor	1	664	Male	6.06	Matched	NA	Alive	Lymph Node	25.44671214	80
prad_mcspc_mskcc_2020	P-0008769	P-0008769-T02-IM5	55	Yes	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1887	IMPACT410	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.25	Stable	NA	4	PRAD	34.3	YES	YES	NO	No	767	NA	Tumor	1	673	Male	8.35	Matched	NA	Alive	Lung	3.91487879	80
prad_mcspc_mskcc_2020	P-0008771	P-0008771-T01-IM5	50	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.1756	IMPACT410	MSKCC	Yes	NA	0.16	Stable	NA	3	PRAD	33.13	YES	YES	NO	No	415	White	Tumor	1	826	Male	22.16	Matched	NA	Alive	Lymph Node	2.936159093	80
prad_mcspc_mskcc_2020	P-0008810	P-0008810-T01-IM5	85	No	NO	<7	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.2990	IMPACT410	MSKCC	No	NA	1.25	Stable	NA	3	PRAD	34.37	YES	YES	NO	No	NA	White	Tumor	1	877	Male	34.37	Matched	NA	Alive	Prostate	2.936159093	60
prad_mcspc_mskcc_2020	P-0008812	P-0008812-T01-IM5	62	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.2354	IMPACT410	MSKCC	Yes	NA	0.45	Stable	NA	1	PRAD	33.48	YES	YES	NO	No	168	White	Tumor	1	961	Male	9.84	Matched	NA	Alive	Prostate	0.978719698	80
prad_mcspc_mskcc_2020	P-0008869	P-0008869-T01-IM5	60	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.0932	IMPACT410	MSKCC	Yes	NA	0.17	Stable	NA	3	PRAD	56.06	YES	NO	NO	No	18	White	Tumor	1	600	Male	40.67	Matched	NA	Dead	Prostate	2.936159093	40
prad_mcspc_mskcc_2020	P-0008920	P-0008920-T01-IM5	60	Yes	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1776	IMPACT410	MSKCC	No	NA	0.31	Stable	524140	4	PRAD	18.13	YES	YES	YES	No	9	White	Tumor	1	699	Male	18.13	Matched	NA	Alive	Other soft tissue	3.91487879	70
prad_mcspc_mskcc_2020	P-0008954	P-0008954-T01-IM5	68	No	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.3322	IMPACT410	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	1.26	Stable	NA	1	PRAD	34.43	YES	YES	NO	No	8	White	Tumor	1	919	Male	12.03	Matched	NA	Alive	Lymph Node	0.978719698	95
prad_mcspc_mskcc_2020	P-0009002	P-0009002-T01-IM5	59	Yes	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.0423	IMPACT410	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	NA	2	PRAD	23.4	YES	YES	NO	No	30	White	Tumor	1	1058	Male	14.94	Matched	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q.	Dead	Liver	1.957439395	20
prad_mcspc_mskcc_2020	P-0009006	P-0009006-T02-IM6	73	Yes	YES	<7	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.2246	IMPACT468	MSKCC	No	MICROSATELLITE INSTABILITY-HIGH (MSI-H). See MSI note below.	22.18	Instable	725813	42	PRAD	0.29	YES	YES	YES	No	7	White	Tumor	1	530	Male	0.29	Matched	NA	Alive	Liver	36.31731999	60
prad_mcspc_mskcc_2020	P-0009044	P-0009044-T01-IM5	61	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.2221	IMPACT410	MSKCC	No	NA	0.16	Stable	NA	5	PRAD	37.6	YES	YES	NO	No	81	White	Tumor	1	936	Male	37.6	Matched	NA	Alive	Prostate	4.893598488	80
prad_mcspc_mskcc_2020	P-0009151	P-0009151-T01-IM5	72	No	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.0379	IMPACT410	MSKCC	No	NA	0.34	Stable	398330	2	PRAD	108.47	YES	YES	YES	No	19	White	Tumor	1	339	Male	106.97	Matched	NA	Alive	Prostate	1.957439395	30
prad_mcspc_mskcc_2020	P-0009361	P-0009361-T01-IM5	70	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.0065	IMPACT410	MSKCC	Yes	NA	0.25	Stable	398102	1	PRAD	24	YES	YES	YES	No	1270	White	Tumor	1	816	Male	20.74	Matched	NA	Alive	Prostate	0.978719698	10
prad_mcspc_mskcc_2020	P-0009399	P-0009399-T01-IM5	75	No	NO	<7	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.5588	IMPACT410	MSKCC	Yes	NA	4.1	Indeterminate	397982	5	PRAD	31.87	YES	YES	YES	No	10	NA	Tumor	1	1211	Male	20.6	Matched	Note: Copy number profile is suggestive of a fragmented genome.	Alive	Other soft tissue	4.893598488	80
prad_mcspc_mskcc_2020	P-0009420	P-0009420-T01-IM5	72	Yes	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0094	IMPACT410	MSKCC	No	NA	0.17	Stable	397856	4	PRAD	36.65	YES	YES	YES	No	1	White	Tumor	1	630	Male	35.1	Matched	NA	Alive	Prostate	3.91487879	30
prad_mcspc_mskcc_2020	P-0009448	P-0009448-T01-IM5	56	No	NO	3+4	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.0102	IMPACT410	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	400310	4	PRAD	1.9	YES	YES	YES	No	5	White	Tumor	1	650	Male	1.9	Matched	NANote: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.NA	Alive	Lymph Node	3.91487879	10
prad_mcspc_mskcc_2020	P-0009463	P-0009463-T01-IM5	76	Yes	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.1390	IMPACT410	MSKCC	Yes	NA	0	Stable	398021	2	PRAD	28.06	YES	YES	YES	No	1	NA	Tumor	1	758	Male	8.1	Matched	NA	Dead	Other soft tissue	1.957439395	20
prad_mcspc_mskcc_2020	P-0009502	P-0009502-T01-IM5	74	No	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.0130	IMPACT410	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	399092	NA	PRAD	55.06	YES	YES	YES	No	6	White	Tumor	1	711	Male	54.68	Matched	Note: Absence of any somatic mutations (including silent mutations) and any copy number changes suggests very low tumor content. Negative results should be interpreted with caution. Repeat testing on a separate sample may be indicated.	Alive	Bone	0	10
prad_mcspc_mskcc_2020	P-0009565	P-0009565-T02-IM5	69	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.1492	IMPACT410	MSKCC	Yes	NA	0.15	Stable	401317	7	PRAD	45.87	YES	YES	YES	No	126	Other	Tumor	1	1014	Male	24.97	Matched	NA	Alive	Prostate	6.851037883	20
prad_mcspc_mskcc_2020	P-0009640	P-0009640-T02-IM6	73	Yes	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.3193	IMPACT468	MSKCC	Yes	NA	1.04	Do not report	504498	2	PRAD	10.32	YES	YES	YES	No	3	White	Tumor	1	199	Male	0.17	Matched	NA	Dead	Bone	1.72939619	40
prad_mcspc_mskcc_2020	P-0009656	P-0009656-T01-IM5	65	Yes	NO	8	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.4492	IMPACT410	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.86	Stable	401034	3	PRAD	9.97	YES	NO	YES	No	7	White	Tumor	1	762	Male	8.79	Matched	NA	Alive	Other soft tissue	2.936159093	30
prad_mcspc_mskcc_2020	P-0009687	P-0009687-T01-IM5	49	No	NO	NA	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.2842	IMPACT410	MSKCC	Yes	NA	0.75	Stable	NA	1	PRAD	53.81	YES	YES	NO	No	238	White	Tumor	1	610	Male	44.23	Matched	NA	Alive	Lymph Node	0.978719698	60
prad_mcspc_mskcc_2020	P-0009787	P-0009787-T01-IM5	62	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.3258	IMPACT410	MSKCC	Yes	NA	0.08	Stable	404222	1	PRAD	32.42	YES	YES	YES	No	6	NA	Tumor	1	642	Male	1.61	Matched	NA	Alive	Prostate	0.978719698	40
prad_mcspc_mskcc_2020	P-0009817	P-0009817-T01-IM5	53	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.2849	IMPACT410	MSKCC	Yes	NA	0	Stable	404119	2	PRAD	89.74	YES	YES	YES	No	117	NA	Tumor	1	520	Male	46.16	Matched	Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	Alive	Prostate	1.957439395	50
prad_mcspc_mskcc_2020	P-0009853	P-0009853-T01-IM5	82	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.2129	IMPACT410	MSKCC	Yes	NA	1	Stable	404021	6	PRAD	28.14	YES	YES	YES	No	170	White	Tumor	1	932	Male	3.58	Matched	NA	Dead	Prostate	5.872318186	50
prad_mcspc_mskcc_2020	P-0009908	P-0009908-T01-IM5	63	Yes	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.0652	IMPACT410	MSKCC	Yes	NA	0.07	Stable	405006	2	PRAD	31.9	YES	YES	YES	No	781	NA	Tumor	1	872	Male	3.57	Matched	NA	Alive	Lymph Node	1.957439395	40
prad_mcspc_mskcc_2020	P-0009989	P-0009989-T01-IM5	56	Yes	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.3444	IMPACT410	MSKCC	Yes	NA	0.79	Stable	405971	5	PRAD	31.3	YES	YES	YES	No	6	White	Tumor	1	1140	Male	0.72	Matched	NA	Alive	Lymph Node	4.893598488	70
prad_mcspc_mskcc_2020	P-0010034	P-0010034-T01-IM5	71	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0004	IMPACT410	MSKCC	No	NA	11.01	Instable	405383	24	PRAD	30.43	YES	YES	YES	No	23	White	Tumor	1	689	Male	30.43	Matched	NA	Alive	Prostate	23.48927274	30
prad_mcspc_mskcc_2020	P-0010178	P-0010178-T02-IM6	75	No	NO	3+4	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.0390	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.61	Stable	667723	1	PRAD	23.5	YES	YES	YES	No	12	White	Tumor	1	691	Male	23.5	Matched	NA	Alive	Lymph Node	0.864698095	50
prad_mcspc_mskcc_2020	P-0010529	P-0010529-T01-IM5	<45	Yes	NO	NA	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.6102	IMPACT410	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	2.05	Stable	404196	3	PRAD	13.58	YES	YES	YES	No	283	NA	Tumor	1	904	Male	7.16	Matched	NA	Alive	Prostate	2.936159093	60
prad_mcspc_mskcc_2020	P-0010538	P-0010538-T01-IM5	82	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.2360	IMPACT410	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	1.06	Stable	415158	8	PRAD	39.68	YES	YES	YES	No	62	White	Tumor	1	450	Male	33.68	Matched	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 7 and Chromosome arms 8q and 9q.	Alive	Prostate	7.829757581	30
prad_mcspc_mskcc_2020	P-0010752	P-0010752-T01-IM5	74	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0012	IMPACT410	MSKCC	No	NA	0.08	Stable	418245	3	PRAD	48.8	YES	YES	YES	No	45	White	Tumor	1	597	Male	48.8	Matched	Note: Low tumor content (approximately 20% or less). Negative copy number and structural variant results should be interpreted with caution.	Alive	Prostate	2.936159093	10
prad_mcspc_mskcc_2020	P-0010796	P-0010796-T01-IM5	72	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.3019	IMPACT410	MSKCC	Yes	NA	1.52	Stable	418658	1	PRAD	30.2	YES	YES	YES	No	71	Black or African American	Tumor	1	930	Male	6.17	Matched	NA	Alive	Lymph Node	0.978719698	50
prad_mcspc_mskcc_2020	P-0011198	P-0011198-T02-IM6	55	Yes	NO	3+4	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.1099	IMPACT468	MSKCC	Yes	NA	0.14	Do not report	508847	1	PRAD	26.33	YES	YES	YES	No	4	White	Tumor	1	875	Male	17.39	Matched	NA	Alive	Lymph Node	0.864698095	40
prad_mcspc_mskcc_2020	P-0011377	P-0011377-T01-IM5	52	No	NO	NA	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.1621	IMPACT410	MSKCC	Yes	NA	1.03	Stable	429400	4	PRAD	25.61	YES	YES	YES	No	170	White	Tumor	1	894	Male	16.55	Matched	NA	Alive	Lymph Node	3.91487879	70
prad_mcspc_mskcc_2020	P-0011399	P-0011399-T01-IM5	56	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.0001	IMPACT410	MSKCC	No	NA	0	Stable	427808	1	PRAD	24.93	YES	YES	YES	No	8	NA	Tumor	1	1210	Male	24.93	Matched	NANote: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.NA	Alive	Lymph Node	0.978719698	10
prad_mcspc_mskcc_2020	P-0011429	P-0011429-T01-IM5	68	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.0956	IMPACT410	MSKCC	Yes	NA	1.18	Stable	429432	1	PRAD	36.53	YES	YES	YES	No	39	White	Tumor	1	224	Male	5.21	Matched	NA	Alive	Prostate	0.978719698	30
prad_mcspc_mskcc_2020	P-0011465	P-0011465-T01-IM5	61	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.0030	IMPACT410	MSKCC	Yes	NA	0	Stable	429353	1	PRAD	32.77	YES	YES	YES	No	148	White	Tumor	1	611	Male	12.48	Matched	NANote: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.NA	Dead	Prostate	0.978719698	20
prad_mcspc_mskcc_2020	P-0011483	P-0011483-T01-IM5	68	Yes	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.2114	IMPACT410	MSKCC	Yes	NA	0.3	Stable	429316	4	PRAD	65.03	YES	NO	YES	No	4	Black or African American	Tumor	1	962	Male	7.5	Matched	NA	Alive	Lung	3.91487879	60
prad_mcspc_mskcc_2020	P-0011515	P-0011515-T01-IM5	68	No	NO	NA	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.0598	IMPACT410	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	430393	1	PRAD	45.73	YES	YES	YES	No	0	White	Tumor	1	846	Male	45.73	Matched	NA	Alive	Prostate	0.978719698	40
prad_mcspc_mskcc_2020	P-0011534	P-0011534-T01-IM5	70	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0262	IMPACT410	MSKCC	No	NA	0	Stable	430452	1	PRAD	27.6	YES	YES	YES	No	11	White	Tumor	1	799	Male	27.6	Matched	NA	Alive	Lymph Node	0.978719698	30
prad_mcspc_mskcc_2020	P-0011553	P-0011553-T01-IM5	76	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0617	IMPACT410	MSKCC	No	NA	0.08	Stable	432168	1	PRAD	46.65	YES	YES	YES	No	7	White	Tumor	1	816	Male	2.63	Matched	NA	Alive	Prostate	0.978719698	40
prad_mcspc_mskcc_2020	P-0011577	P-0011577-T01-IM5	70	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1354	IMPACT410	MSKCC	No	NA	0	Stable	432238	6	PRAD	15.19	YES	YES	YES	No	652	White	Tumor	1	884	Male	12.33	Matched	NA	Dead	Prostate	5.872318186	50
prad_mcspc_mskcc_2020	P-0012029	P-0012029-T01-IM5	61	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.0556	IMPACT410	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.18	Stable	432303	NA	PRAD	38.64	YES	YES	YES	No	206	White	Tumor	1	862	Male	12.42	Matched	NA	Dead	Prostate	0	50
prad_mcspc_mskcc_2020	P-0012030	P-0012030-T01-IM5	56	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.0870	IMPACT410	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.19	Stable	432135	2	PRAD	59.06	YES	YES	YES	No	393	Black or African American	Tumor	1	815	Male	17.4	Matched	NA	Dead	Prostate	1.957439395	60
prad_mcspc_mskcc_2020	P-0012031	P-0012031-T01-IM5	80	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.0525	IMPACT410	MSKCC	Yes	NA	0.68	Stable	432141	1	PRAD	35.13	YES	YES	YES	No	5	NA	Tumor	1	440	Male	4.55	Matched	NA	Dead	Prostate	0.978719698	90
prad_mcspc_mskcc_2020	P-0012048	P-0012048-T02-IM5	76	Yes	NO	<7	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.3517	IMPACT410	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.75	Stable	449832	3	PRAD	28.52	YES	YES	YES	No	4	White	Tumor	1	1005	Male	1.55	Matched	NANote: Copy number profile is suggestive of broad copy number losses on Chromosome arms.2q11-31, 2q36-37, 4q21-24, 13q14-22, 16q, and 22q losses. Note: Copy number profile is suggestive of broad copy number gains on Chromosome arms 1q22-25 and 3q21-28.NA	Dead	Bone	2.936159093	20
prad_mcspc_mskcc_2020	P-0012132	P-0012132-T01-IM5	59	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.2210	IMPACT410	MSKCC	Yes	NA	0.28	Stable	434372	2	PRAD	35.37	YES	YES	YES	No	131	NA	Tumor	1	754	Male	12.13	Matched	NA	Alive	Prostate	1.957439395	40
prad_mcspc_mskcc_2020	P-0012136	P-0012136-T01-IM5	69	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.2023	IMPACT410	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.84	Stable	434438	NA	PRAD	19.03	YES	YES	YES	No	361	White	Tumor	1	171	Male	6.55	Matched	NANote: Low sequencing depth of coverage of 171X, negative results should be interpreted with caution.NA	Dead	Prostate	0	60
prad_mcspc_mskcc_2020	P-0012181	P-0012181-T02-IM6	62	Yes	NO	3+4	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.2203	IMPACT468	MSKCC	No	NA	0	Do not report	515770	5	PRAD	16.68	YES	YES	YES	No	3	White	Tumor	1	880	Male	16.68	Matched	NA	Alive	Lymph Node	4.323490475	30
prad_mcspc_mskcc_2020	P-0012230	P-0012230-T01-IM5	>85	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.0952	IMPACT410	MSKCC	No	NA	0	Stable	435679	35	PRAD	27.48	YES	YES	YES	No	35	NA	Tumor	1	863	Male	27.16	Matched	NA	Dead	Prostate	34.25518942	50
prad_mcspc_mskcc_2020	P-0012304	P-0012304-T01-IM5	66	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.0026	IMPACT410	MSKCC	No	NA	0	Stable	437804	1	PRAD	5.74	YES	YES	YES	No	100	NA	Tumor	1	895	Male	2.77	Matched	NANote: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.NA	Alive	Prostate	0.978719698	20
prad_mcspc_mskcc_2020	P-0012326	P-0012326-T01-IM5	68	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1220	IMPACT410	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.09	Stable	437363	5	PRAD	35.2	YES	YES	YES	No	708	White	Tumor	1	615	Male	18.63	Matched	NA	Alive	Prostate	4.893598488	50
prad_mcspc_mskcc_2020	P-0012375	P-0012375-T01-IM5	69	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.2373	IMPACT410	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.44	Stable	NA	3	PRAD	53.57	YES	YES	NO	No	11	White	Tumor	1	629	Male	46.9	Matched	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q.	Alive	Prostate	2.936159093	80
prad_mcspc_mskcc_2020	P-0012513	P-0012513-T01-IM5	63	Yes	NO	8	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.1019	IMPACT410	MSKCC	Yes	NA	0.16	Stable	438477	6	PRAD	61.84	YES	YES	YES	No	6	NA	Tumor	1	772	Male	35.65	Matched	NA	Alive	Lymph Node	5.872318186	60
prad_mcspc_mskcc_2020	P-0012555	P-0012555-T01-IM5	60	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.1184	IMPACT410	MSKCC	Yes	NA	0.28	Stable	442149	1	PRAD	34.61	YES	YES	YES	No	21	White	Tumor	1	1036	Male	23	Matched	NA	Dead	Lymph Node	0.978719698	60
prad_mcspc_mskcc_2020	P-0012630	P-0012630-T01-IM5	67	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.2618	IMPACT410	MSKCC	Yes	NA	0.15	Stable	448819	2	PRAD	42.47	YES	NO	YES	No	5	White	Tumor	1	636	Male	14.19	Matched	NA	Alive	Lymph Node	1.957439395	60
prad_mcspc_mskcc_2020	P-0012643	P-0012643-T01-IM5	53	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.4849	IMPACT410	MSKCC	No	NA	1.11	Stable	441788	3	PRAD	37.07	YES	YES	YES	No	10	White	Tumor	1	1015	Male	27.77	Matched	Note: Copy number profile is suggestive of a fragmented genome.	Alive	Bone	2.936159093	60
prad_mcspc_mskcc_2020	P-0012711	P-0012711-T01-IM5	74	No	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.1628	IMPACT410	MSKCC	No	NA	0	Stable	449056	8	PRAD	33.1	YES	YES	YES	No	7	NA	Tumor	1	866	Male	31.68	Matched	NA	Alive	Lung	7.829757581	40
prad_mcspc_mskcc_2020	P-0012914	P-0012914-T01-IM5	60	No	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.3406	IMPACT410	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	1.35	Stable	448108	2	PRAD	31.55	YES	YES	YES	No	8	Black or African American	Tumor	1	1104	Male	23.19	Matched	NA	Alive	Lymph Node	1.957439395	80
prad_mcspc_mskcc_2020	P-0012928	P-0012928-T01-IM5	51	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0024	IMPACT410	MSKCC	No	NA	20.21	Instable	449628	44	PRAD	22.48	YES	YES	YES	No	55	White	Tumor	1	311	Male	6.53	Matched	NA	Dead	Lymph Node	43.0636667	30
prad_mcspc_mskcc_2020	P-0013000	P-0013000-T01-IM5	84	Yes	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.1712	IMPACT410	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	449801	5	PRAD	11.7	YES	YES	YES	No	3	White	Tumor	1	942	Male	1.37	Matched	NA	Dead	Bone	4.893598488	40
prad_mcspc_mskcc_2020	P-0013030	P-0013030-T01-IM5	48	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0562	IMPACT410	MSKCC	No	NA	2.56	Stable	449840	1	PRAD	104.39	YES	YES	YES	No	9	White	Tumor	1	103	Male	104.39	Matched	NANote: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.NA	Alive	Prostate	0.978719698	10
prad_mcspc_mskcc_2020	P-0013036	P-0013036-T01-IM5	73	Yes	NO	3+4	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.1205	IMPACT410	MSKCC	Yes	NA	0.22	Stable	451514	6	PRAD	27.3	YES	YES	YES	No	16	White	Tumor	1	793	Male	23.74	Matched	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q21-24.	Alive	Bone	5.872318186	20
prad_mcspc_mskcc_2020	P-0013037	P-0013037-T02-IM5	66	Yes	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.0078	IMPACT410	MSKCC	No	NA	0	Do not report	556127	1	PRAD	21.33	YES	YES	YES	No	4	White	Tumor	1	1284	Male	20.48	Matched	NANote: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.NA	Alive	Bone	0.978719698	10
prad_mcspc_mskcc_2020	P-0013115	P-0013115-T01-IM5	72	No	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.2716	IMPACT410	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.76	Stable	451871	6	PRAD	83.35	YES	YES	YES	No	7	White	Tumor	1	833	Male	60.13	Matched	NA	Alive	Lung	5.872318186	80
prad_mcspc_mskcc_2020	P-0013223	P-0013223-T02-IM6	56	No	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.0134	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0	Stable	616639	2	PRAD	16.13	YES	YES	YES	No	35	White	Tumor	1	836	Male	16.13	Matched	NA	Alive	Bone	1.72939619	30
prad_mcspc_mskcc_2020	P-0013526	P-0013526-T01-IM5	64	Yes	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.5418	IMPACT410	MSKCC	Yes	NA	0.73	Stable	460423	4	PRAD	21.73	YES	YES	YES	No	42	White	Tumor	1	767	Male	8.32	Matched	Note: Copy number profile is suggestive of a fragmented genome.	Dead	Bone	3.91487879	60
prad_mcspc_mskcc_2020	P-0013674	P-0013674-T01-IM5	66	Yes	NO	8	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.1832	IMPACT410	MSKCC	Yes	NA	0.41	Stable	461075	1	PRAD	26.37	YES	YES	YES	No	3	White	Tumor	1	1062	Male	20.87	Matched	NA	Alive	Liver	0.978719698	50
prad_mcspc_mskcc_2020	P-0013681	P-0013681-T01-IM5	85	Yes	NO	3+4	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.1235	IMPACT410	MSKCC	Yes	NA	0.15	Stable	663228	1	PRAD	27.33	YES	YES	YES	No	11	White	Tumor	1	804	Male	3.1	Matched	NA	Alive	Lung	0.978719698	30
prad_mcspc_mskcc_2020	P-0013729	P-0013729-T01-IM5	62	Yes	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.2539	IMPACT410	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	1.01	Stable	464335	NA	PRAD	40.61	YES	YES	YES	No	8	White	Tumor	1	862	Male	14.5	Matched	NANote: Copy number profile is suggestive of broad copy number gains on Chromosome arms 2p and 5q.Note: Copy number profile is suggestive of broad copy number losses on Chromosome 10 and Chromosome arms 7p21-p22, 11q23, 13q14-q22, and 16q.NA	Alive	Lymph Node	0	80
prad_mcspc_mskcc_2020	P-0013837	P-0013837-T01-IM5	64	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1497	IMPACT410	MSKCC	Yes	NA	0.58	Do not report	467026	2	PRAD	36.97	YES	YES	YES	No	37	White	Tumor	1	999	Male	34.37	Matched	NA	Alive	Prostate	1.957439395	70
prad_mcspc_mskcc_2020	P-0013858	P-0013858-T01-IM5	69	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.1982	IMPACT410	MSKCC	No	NA	0.67	Do not report	466984	5	PRAD	2.23	YES	YES	YES	No	4	White	Tumor	1	885	Male	0	Matched	NA	Alive	Bone	4.893598488	30
prad_mcspc_mskcc_2020	P-0013865	P-0013865-T01-IM5	83	No	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.3153	IMPACT410	MSKCC	Yes	NA	0.64	Do not report	468062	1	PRAD	16.73	YES	YES	YES	No	6	White	Tumor	1	973	Male	7.71	Matched	NA	Dead	Lymph Node	0.978719698	60
prad_mcspc_mskcc_2020	P-0014004	P-0014004-T02-IM6	70	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.6039	IMPACT468	MSKCC	Yes	NA	1.09	Do not report	498621	6	PRAD	21.37	YES	YES	YES	No	23	White	Tumor	1	764	Male	3.48	Matched	NA	Dead	Other soft tissue	5.18818857	60
prad_mcspc_mskcc_2020	P-0014076	P-0014076-T01-IM5	56	Yes	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.1893	IMPACT410	MSKCC	Yes	NA	0.46	Stable	473695	6	PRAD	3.87	YES	YES	YES	No	418	White	Tumor	1	1194	Male	1.06	Matched	NANote: Copy number profile is suggestive of broad copy number gain on Chromosome arm 5p. Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 3p11-21, 3q27-28, 9p, 13q, and 18q.NA	Dead	Lymph Node	5.872318186	40
prad_mcspc_mskcc_2020	P-0014202	P-0014202-T01-IM6	66	Yes	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0010	IMPACT468	MSKCC	No	NA	0	Do not report	476971	2	PRAD	44.63	YES	NO	YES	No	42	NA	Tumor	1	747	Male	44.63	Matched	Note: Low tumor content (approximately 20% or less). Negative results should be interpreted with caution.	Alive	Prostate	1.72939619	20
prad_mcspc_mskcc_2020	P-0014204	P-0014204-T01-IM6	75	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.3373	IMPACT468	MSKCC	Yes	NA	1.13	Do not report	476964	3	PRAD	25.47	YES	YES	YES	No	3	Black or African American	Tumor	1	903	Male	6.61	Matched	NA	Alive	Other soft tissue	2.594094285	70
prad_mcspc_mskcc_2020	P-0014254	P-0014254-T02-IM6	68	No	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.2636	IMPACT468	MSKCC	No	NA	0.54	Do not report	529440	1	PRAD	18.65	YES	YES	YES	No	8	White	Tumor	1	1209	Male	18.65	Matched	NA	Alive	Lymph Node	0.864698095	60
prad_mcspc_mskcc_2020	P-0014299	P-0014299-T01-IM6	66	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.5170	IMPACT468	MSKCC	Yes	NA	1.86	Do not report	479135	4	PRAD	23.23	YES	YES	YES	No	NA	White	Tumor	1	297	Male	11.26	Matched	Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	Dead	Prostate	3.45879238	70
prad_mcspc_mskcc_2020	P-0014395	P-0014395-T01-IM6	69	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.2178	IMPACT468	MSKCC	Yes	NA	0.43	Do not report	480752	2	PRAD	39.33	YES	YES	YES	No	12	NA	Tumor	1	726	Male	38.45	Matched	NA	Alive	Prostate	1.72939619	20
prad_mcspc_mskcc_2020	P-0014438	P-0014438-T01-IM6	66	No	NO	3+4	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.6124	IMPACT468	MSKCC	Yes	NA	2.45	Do not report	482622	3	PRAD	36.3	YES	YES	YES	No	4	White	Tumor	1	666	Male	11.9	Matched	NA	Alive	Lymph Node	2.594094285	80
prad_mcspc_mskcc_2020	P-0014467	P-0014467-T01-IM6	45	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.1060	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.72	Stable	483867	4	PRAD	30.97	YES	YES	YES	No	86	Black or African American	Tumor	1	918	Male	7.97	Matched	NA	Alive	Prostate	3.45879238	80
prad_mcspc_mskcc_2020	P-0014530	P-0014530-T01-IM6	80	No	NO	<7	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.0022	IMPACT468	MSKCC	No	NA	0.07	Do not report	483407	4	PRAD	23	YES	YES	YES	No	4	White	Tumor	1	840	Male	23	Matched	NANote: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.NA	Alive	Other soft tissue	3.45879238	10
prad_mcspc_mskcc_2020	P-0014557	P-0014557-T01-IM6	68	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.4135	IMPACT468	MSKCC	Yes	NA	0.13	Do not report	485039	4	PRAD	19.71	YES	YES	YES	No	52	White	Tumor	1	859	Male	8	Matched	NA	Dead	Prostate	3.45879238	30
prad_mcspc_mskcc_2020	P-0014571	P-0014571-T01-IM6	77	Yes	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.4335	IMPACT468	MSKCC	No	NA	0.21	Do not report	484528	5	PRAD	0	YES	YES	YES	No	NA	Black or African American	Tumor	1	927	Male	0	Matched	NA	Alive	Lymph Node	4.323490475	50
prad_mcspc_mskcc_2020	P-0014597	P-0014597-T01-IM6	52	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.0425	IMPACT468	MSKCC	No	NA	0.06	Do not report	NA	2	PRAD	27.84	YES	YES	NO	No	1334	NA	Tumor	1	762	Male	27.84	Matched	NA	Alive	Prostate	1.72939619	40
prad_mcspc_mskcc_2020	P-0014598	P-0014598-T01-IM6	76	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.1242	IMPACT468	MSKCC	No	NA	0.12	Do not report	487314	3	PRAD	22.58	YES	NO	YES	No	15	NA	Tumor	1	729	Male	22.58	Matched	NA	Alive	Bone	2.594094285	10
prad_mcspc_mskcc_2020	P-0014629	P-0014629-T01-IM6	71	Yes	NO	8	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.1918	IMPACT468	MSKCC	No	NA	0.21	Do not report	487361	3	PRAD	9.2	YES	YES	YES	No	5	White	Tumor	1	704	Male	1.84	Matched	NA	Alive	Bone	1.72939619	20
prad_mcspc_mskcc_2020	P-0014686	P-0014686-T01-IM6	68	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.2895	IMPACT468	MSKCC	No	NA	0.18	Do not report	487311	NA	PRAD	32.1	YES	YES	YES	No	47	White	Tumor	1	600	Male	32.1	Matched	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q13-21.	Alive	Prostate	0	30
prad_mcspc_mskcc_2020	P-0015026	P-0015026-T01-IM6	67	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.0169	IMPACT468	MSKCC	No	NA	0	Do not report	NA	2	PRAD	34.1	YES	YES	NO	No	64	White	Tumor	1	888	Male	33.23	Matched	NANote: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.NA	Alive	Prostate	1.72939619	20
prad_mcspc_mskcc_2020	P-0015064	P-0015064-T01-IM6	58	Yes	NO	NA	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1715	IMPACT468	MSKCC	No	NA	0.15	Do not report	498493	4	PRAD	7.8	YES	YES	YES	No	793	White	Tumor	1	692	Male	5.86	Matched	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 13q13-13q22.	Alive	Lymph Node	3.45879238	20
prad_mcspc_mskcc_2020	P-0015070	P-0015070-T01-IM6	47	Yes	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0949	IMPACT468	MSKCC	Yes	NA	0.15	Do not report	498406	5	PRAD	26.61	YES	YES	YES	No	19	Other	Tumor	1	698	Male	9.84	Matched	NA	Alive	Bone	4.323490475	20
prad_mcspc_mskcc_2020	P-0015102	P-0015102-T01-IM6	67	Yes	NO	8	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.2129	IMPACT468	MSKCC	No	NA	0.12	Do not report	498551	4	PRAD	24.19	YES	YES	YES	No	11	White	Tumor	1	807	Male	24.19	Matched	NA	Alive	Lymph Node	3.45879238	50
prad_mcspc_mskcc_2020	P-0015209	P-0015209-T01-IM6	76	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.1451	IMPACT468	MSKCC	Yes	NA	0	Do not report	500832	3	PRAD	12.94	YES	YES	YES	No	11	White	Tumor	1	809	Male	4.29	Matched	NA	Dead	Lymph Node	2.594094285	30
prad_mcspc_mskcc_2020	P-0015211	P-0015211-T01-IM6	67	No	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.1926	IMPACT468	MSKCC	Yes	NA	6.83	Do not report	498766	16	PRAD	33.4	YES	NO	YES	No	133	White	Tumor	1	782	Male	22.84	Matched	NA	Alive	Bone	13.83516952	40
prad_mcspc_mskcc_2020	P-0015239	P-0015239-T01-IM6	77	Yes	NO	8	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.0944	IMPACT468	MSKCC	Yes	NA	0.37	Do not report	497683	3	PRAD	30.48	YES	YES	YES	No	2	White	Tumor	1	607	Male	12.17	Matched	NA	Alive	Other soft tissue	2.594094285	50
prad_mcspc_mskcc_2020	P-0015278	P-0015278-T02-IM6	66	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0	Stable	594061	2	PRAD	25	YES	YES	YES	No	8	White	Tumor	1	799	Male	16.71	Matched	NANote: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.NA	Alive	Lymph Node	1.72939619	10
prad_mcspc_mskcc_2020	P-0015302	P-0015302-T01-IM6	60	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.3105	IMPACT468	MSKCC	Yes	NA	0.46	Do not report	501600	3	PRAD	15.3	YES	YES	YES	No	1430	White	Tumor	1	780	Male	5.23	Matched	NA	Dead	Prostate	2.594094285	40
prad_mcspc_mskcc_2020	P-0015452	P-0015452-T01-IM6	63	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.0288	IMPACT468	MSKCC	Yes	NA	1.89	Do not report	504986	5	PRAD	57.63	YES	YES	YES	No	21	White	Tumor	1	141	Male	15.48	Matched	NANote: Please note that this sample did not meet the minimum criteria for overall sequence coverage, raising the risk of false negative results.  We can confirm the presence of the genomic alterations outlined in the report but false negative results can	Dead	Prostate	4.323490475	30
prad_mcspc_mskcc_2020	P-0015547	P-0015547-T02-IM6	58	No	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0469	IMPACT468	MSKCC	No	NA	0.15	Do not report	526259	2	PRAD	26.71	YES	YES	YES	No	7	NA	Tumor	1	951	Male	26.03	Matched	NANote: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.NA	Alive	Prostate	1.72939619	20
prad_mcspc_mskcc_2020	P-0015767	P-0015767-T01-IM6	70	No	NO	NA	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0321	IMPACT468	MSKCC	No	NA	0.12	Do not report	514981	5	PRAD	30.27	YES	YES	YES	No	16	White	Tumor	1	818	Male	11.27	Matched	NANote: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.NA	Alive	Prostate	4.323490475	10
prad_mcspc_mskcc_2020	P-0015962	P-0015962-T01-IM6	55	No	NO	<7	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.3342	IMPACT468	MSKCC	No	NA	0.34	Do not report	517761	4	PRAD	20.5	YES	YES	YES	No	10	White	Tumor	1	853	Male	15.7	Matched	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q.	Alive	Lymph Node	3.45879238	40
prad_mcspc_mskcc_2020	P-0016059	P-0016059-T01-IM6	58	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.0035	IMPACT468	MSKCC	Yes	NA	0.08	Do not report	520025	2	PRAD	23.67	YES	NO	YES	No	96	White	Tumor	1	294	Male	11.73	Matched	NANote: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.NA	Dead	Prostate	1.72939619	20
prad_mcspc_mskcc_2020	P-0016214	P-0016214-T01-IM6	69	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1611	IMPACT468	MSKCC	Yes	NA	0.14	Do not report	526132	8	PRAD	36.6	YES	YES	YES	No	3134	Other	Tumor	1	762	Male	24.33	Matched	NA	Alive	Prostate	6.91758476	60
prad_mcspc_mskcc_2020	P-0016396	P-0016396-T01-IM6	71	Yes	NO	3+4	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.1295	IMPACT468	MSKCC	Yes	NA	0.57	Do not report	524158	2	PRAD	11.19	YES	YES	YES	No	7	White	Tumor	1	893	Male	0.03	Matched	NA	Dead	Other soft tissue	1.72939619	60
prad_mcspc_mskcc_2020	P-0016405	P-0016405-T01-IM6	79	Yes	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.1982	IMPACT468	MSKCC	No	NA	0.41	Do not report	525642	1	PRAD	20.77	YES	YES	YES	No	7	White	Tumor	1	709	Male	20.77	Matched	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 8.	Alive	Other soft tissue	0.864698095	50
prad_mcspc_mskcc_2020	P-0016446	P-0016446-T01-IM6	74	Yes	NO	3+4	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.4072	IMPACT468	MSKCC	Yes	NA	1.33	Do not report	529436	5	PRAD	126.68	YES	YES	YES	No	10	White	Tumor	1	372	Male	102.77	Matched	Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	Alive	Lung	4.323490475	80
prad_mcspc_mskcc_2020	P-0016450	P-0016450-T01-IM6	77	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.3099	IMPACT468	MSKCC	Yes	NA	1.02	Do not report	528642	1	PRAD	21.45	YES	YES	YES	No	35	Black or African American	Tumor	1	770	Male	0.03	Matched	NA	Alive	Lymph Node	0.864698095	60
prad_mcspc_mskcc_2020	P-0016731	P-0016731-T01-IM6	80	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.1937	IMPACT468	MSKCC	Yes	NA	1.68	Do not report	533519	7	PRAD	65.63	YES	YES	YES	No	28	White	Tumor	1	556	Male	32.17	Matched	Note: The copy number profile is suggestive of broad copy number loss on Chromosome arm 19p13.12 - 19p13.3.	Alive	Prostate	6.052886665	50
prad_mcspc_mskcc_2020	P-0016733	P-0016733-T01-IM6	58	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1699	IMPACT468	MSKCC	Yes	NA	0.35	Do not report	533564	9	PRAD	61.43	YES	NO	YES	No	76	White	Tumor	1	861	Male	10.39	Matched	NA	Alive	Prostate	7.782282855	70
prad_mcspc_mskcc_2020	P-0016768	P-0016768-T01-IM6	56	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.4359	IMPACT468	MSKCC	Yes	NA	0.68	Do not report	536961	10	PRAD	23.9	YES	YES	YES	No	56	NA	Tumor	1	319	Male	5.84	Matched	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q.	Dead	Bone	8.64698095	50
prad_mcspc_mskcc_2020	P-0016895	P-0016895-T01-IM6	70	No	NO	<7	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.0280	IMPACT468	MSKCC	No	NA	0	Do not report	541895	3	PRAD	24.19	YES	YES	YES	No	3	White	Tumor	1	937	Male	24.19	Matched	NA	Alive	Other soft tissue	2.594094285	10
prad_mcspc_mskcc_2020	P-0016911	P-0016911-T01-IM6	67	No	NO	NA	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.0869	IMPACT468	MSKCC	No	NA	0.65	Do not report	540894	1	PRAD	21.67	YES	YES	YES	No	8871	Other	Tumor	1	949	Male	20.77	Matched	NA	Alive	Lymph Node	0.864698095	60
prad_mcspc_mskcc_2020	P-0016990	P-0016990-T01-IM6	61	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.2526	IMPACT468	MSKCC	Yes	NA	1.39	Do not report	543167	2	PRAD	52.13	YES	YES	YES	No	18	NA	Tumor	1	579	Male	27.2	Matched	NA	Dead	Prostate	1.72939619	60
prad_mcspc_mskcc_2020	P-0017041	P-0017041-T01-IM6	63	No	NO	9-11	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.5538	IMPACT468	MSKCC	No	NA	1.49	Do not report	544915	7	PRAD	9.64	YES	YES	YES	No	348	NA	Tumor	1	947	Male	7.13	Matched	NA	Alive	Prostate	6.052886665	50
prad_mcspc_mskcc_2020	P-0017097	P-0017097-T01-IM6	83	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.2024	IMPACT468	MSKCC	Yes	NA	0.44	Do not report	543753	7	PRAD	9.58	YES	YES	YES	No	17	White	Tumor	1	1012	Male	7.1	Matched	NA	Dead	Prostate	6.052886665	80
prad_mcspc_mskcc_2020	P-0017543	P-0017543-T01-IM5	74	No	NO	<7	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.4694	IMPACT410	MSKCC	Yes	NA	0.4	Do not report	580416	5	PRAD	28.03	YES	YES	YES	No	14	NA	Tumor	1	637	Male	5.48	Matched	NA	Alive	Prostate	4.893598488	40
prad_mcspc_mskcc_2020	P-0017548	P-0017548-T01-IM5	70	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.3193	IMPACT410	MSKCC	Yes	NA	0	Do not report	562219	5	PRAD	19.6	YES	YES	YES	No	30	NA	Tumor	1	482	Male	6.48	Matched	NA	Dead	Liver	4.893598488	30
prad_mcspc_mskcc_2020	P-0017703	P-0017703-T01-IM6	58	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.3266	IMPACT468	MSKCC	Yes	NA	0.15	Do not report	558326	3	PRAD	26.3	YES	YES	YES	No	11	White	Tumor	1	559	Male	13.06	Matched	NA	Alive	Prostate	2.594094285	60
prad_mcspc_mskcc_2020	P-0017754	P-0017754-T01-IM6	62	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0127	IMPACT468	MSKCC	Yes	NA	0.08	Do not report	558138	4	PRAD	30.42	YES	YES	YES	No	7	White	Tumor	1	800	Male	20.29	Matched	NANote: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.NA	Alive	Prostate	3.45879238	30
prad_mcspc_mskcc_2020	P-0017810	P-0017810-T01-IM6	72	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.0307	IMPACT468	MSKCC	Yes	NA	0.13	Do not report	558327	2	PRAD	21	YES	YES	YES	No	NA	Black or African American	Tumor	1	698	Male	12.43	Matched	NA	Alive	Prostate	1.72939619	40
prad_mcspc_mskcc_2020	P-0017890	P-0017890-T01-IM6	48	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.4170	IMPACT468	MSKCC	Yes	NA	1.12	Do not report	567285	3	PRAD	20.03	YES	YES	YES	No	9	White	Tumor	1	251	Male	8.55	Matched	Note: Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	Dead	Prostate	2.594094285	40
prad_mcspc_mskcc_2020	P-0017892	P-0017892-T01-IM6	82	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.2209	IMPACT468	MSKCC	Yes	NA	0.29	Do not report	563073	6	PRAD	22.3	YES	YES	YES	No	44	NA	Tumor	1	583	Male	9.68	Matched	NA	Alive	Prostate	5.18818857	40
prad_mcspc_mskcc_2020	P-0018086	P-0018086-T01-IM6	53	Yes	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.2100	IMPACT468	MSKCC	No	NA	0	Do not report	566383	7	PRAD	18	YES	YES	YES	No	2	White	Tumor	1	987	Male	18	Matched	NA	Alive	Lung	6.052886665	50
prad_mcspc_mskcc_2020	P-0018178	P-0018178-T01-IM6	85	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.0194	IMPACT468	MSKCC	Yes	NA	0	Do not report	573442	1	PRAD	33.5	YES	YES	YES	No	17	White	Tumor	1	741	Male	7.1	Matched	NA	Alive	Prostate	0.864698095	10
prad_mcspc_mskcc_2020	P-0018221	P-0018221-T01-IM6	85	No	NO	NA	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0177	IMPACT468	MSKCC	No	NA	0.19	Do not report	574119	2	PRAD	19.07	YES	YES	YES	No	3022	White	Tumor	1	686	Male	18.61	Matched	Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 6q21-22 and 8p.	Alive	Lymph Node	1.72939619	50
prad_mcspc_mskcc_2020	P-0018395	P-0018395-T01-IM6	80	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1438	IMPACT468	MSKCC	Yes	NA	0.08	Do not report	579624	6	PRAD	58.13	YES	NO	YES	No	97	Other	Tumor	1	774	Male	12.6	Matched	NA	Alive	Prostate	5.18818857	30
prad_mcspc_mskcc_2020	P-0018489	P-0018489-T01-IM6	78	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.0506	IMPACT468	MSKCC	No	NA	0	Do not report	584611	7	PRAD	1.65	YES	NO	YES	No	4	White	Tumor	1	689	Male	0	Matched	NA	Alive	Liver	6.052886665	20
prad_mcspc_mskcc_2020	P-0018668	P-0018668-T01-IM6	61	No	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.1060	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0	Stable	583640	4	PRAD	31.3	YES	YES	YES	No	12	White	Tumor	1	665	Male	31.3	Matched	NA	Alive	Prostate	3.45879238	30
prad_mcspc_mskcc_2020	P-0018703	P-0018703-T01-IM6	56	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1737	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	1.04	Stable	586365	NA	PRAD	23.29	YES	YES	YES	No	1038	White	Tumor	1	334	Male	17.63	Matched	NANote: Low tumor content (approximately 15% based on variant frequencies of silent mutations and morphology). Negative mutation, MSIsensor, copy number and structural variant results should be interpreted with caution.NA	Alive	Prostate	0	30
prad_mcspc_mskcc_2020	P-0018779	P-0018779-T01-IM6	55	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.4172	IMPACT468	MSKCC	Yes	MICROSATELLITE INSTABILITY-INDETERMINATE. This result is for investigational use only. See MSI note below.	3.61	Indeterminate	585838	5	PRAD	56.07	YES	YES	YES	No	351	Black or African American	Tumor	1	231	Male	22.97	Matched	NA	Alive	Prostate	4.323490475	60
prad_mcspc_mskcc_2020	P-0018798	P-0018798-T01-IM6	59	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1286	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.3	Stable	585784	3	PRAD	18.35	YES	NO	YES	No	3612	NA	Tumor	1	622	Male	12.35	Matched	NA	Dead	Prostate	2.594094285	50
prad_mcspc_mskcc_2020	P-0018812	P-0018812-T01-IM6	76	No	YES	NA	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.4645	IMPACT468	MSKCC	Yes	NA	1.14	Do not report	587331	4	PRAD	25.77	YES	NO	YES	No	5	NA	Tumor	1	570	Male	1.42	Matched	Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	Alive	Lymph Node	3.45879238	50
prad_mcspc_mskcc_2020	P-0018870	P-0018870-T01-IM6	71	No	NO	NA	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.6327	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.9	Stable	588971	2	PRAD	13.16	YES	YES	YES	No	556	White	Tumor	1	793	Male	3.35	Matched	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 13q14-q22.	Dead	Bone	1.72939619	40
prad_mcspc_mskcc_2020	P-0019030	P-0019030-T01-IM6	71	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.1847	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.18	Stable	591878	3	PRAD	17.74	YES	YES	YES	No	6	NA	Tumor	1	810	Male	7.77	Matched	NA	Alive	Bone	2.594094285	30
prad_mcspc_mskcc_2020	P-0019059	P-0019059-T01-IM6	54	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1917	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.34	Stable	593539	3	PRAD	34.94	YES	YES	YES	No	1280	White	Tumor	1	385	Male	12.68	Matched	NA	Alive	Prostate	2.594094285	50
prad_mcspc_mskcc_2020	P-0019581	P-0019581-T02-IM6	67	No	YES	9-10	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.0811	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.21	Stable	981722	2	PRAD	15.2	YES	YES	YES	No	42	Black or African American	Tumor	1	736	Male	11.03	Matched	NA	Dead	Bone	1.72939619	30
prad_mcspc_mskcc_2020	P-0019584	P-0019584-T01-IM6	61	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0919	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.57	Stable	606928	4	PRAD	10.58	YES	YES	YES	No	233	Black or African American	Tumor	1	694	Male	1.1	Matched	NANote: Copy number profile is suggestive of broad copy number loss on Chromosome arms 2p22-23, 8p, 12p12-13, 16p13.3, and 16q12-34.NA	Dead	Prostate	3.45879238	60
prad_mcspc_mskcc_2020	P-0019624	P-0019624-T01-IM6	69	Yes	NO	NA	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.4434	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	1.45	Stable	607856	4	PRAD	19.63	YES	NO	YES	No	64	NA	Tumor	1	705	Male	3.77	Matched	NA	Dead	Bone	3.45879238	50
prad_mcspc_mskcc_2020	P-0019695	P-0019695-T01-IM6	61	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1883	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.6	Stable	607892	3	PRAD	51.36	YES	YES	YES	No	1756	White	Tumor	1	361	Male	27.79	Matched	NANote: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.NA	Dead	Prostate	2.594094285	20
prad_mcspc_mskcc_2020	P-0019918	P-0019918-T01-IM6	75	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.0831	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.71	Stable	616422	4	PRAD	24.87	YES	NO	YES	No	NA	White	Tumor	1	217	Male	24.87	Matched	NA	Alive	Lung	3.45879238	30
prad_mcspc_mskcc_2020	P-0019927	P-0019927-T01-IM6	67	No	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.4698	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	1.11	Stable	616432	5	PRAD	32.94	YES	YES	YES	No	6	Other	Tumor	1	918	Male	12.71	Matched	NA	Alive	Other soft tissue	4.323490475	50
prad_mcspc_mskcc_2020	P-0020023	P-0020023-T01-IM6	71	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.2949	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0	Stable	616875	2	PRAD	22.07	YES	YES	YES	No	2	White	Tumor	1	514	Male	8	Matched	NA	Alive	Lung	1.72939619	60
prad_mcspc_mskcc_2020	P-0020078	P-0020078-T01-IM6	67	No	YES	4+3	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.3816	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.13	Stable	617787	5	PRAD	17.13	YES	YES	YES	No	10	White	Tumor	1	676	Male	14.2	Matched	NA	Alive	Lymph Node	4.323490475	60
prad_mcspc_mskcc_2020	P-0020218	P-0020218-T01-IM6	65	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.6759	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.91	Stable	618802	6	PRAD	16.84	YES	YES	YES	No	74	Black or African American	Tumor	1	927	Male	16.77	Matched	NA	Alive	Liver	5.18818857	80
prad_mcspc_mskcc_2020	P-0020424	P-0020424-T01-IM6	<45	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1884	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.46	Stable	625937	5	PRAD	15.7	YES	YES	YES	No	284	White	Tumor	1	811	Male	7.19	Matched	NA	Alive	Prostate	4.323490475	50
prad_mcspc_mskcc_2020	P-0020492	P-0020492-T01-IM6	66	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.0059	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.21	Stable	627205	3	PRAD	11.77	YES	YES	YES	No	453	White	Tumor	1	667	Male	2.58	Matched	NANote: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.NA	Alive	Prostate	2.594094285	20
prad_mcspc_mskcc_2020	P-0020512	P-0020512-T01-IM6	67	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.0106	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.13	Stable	628717	2	PRAD	17.43	YES	YES	YES	No	5	White	Tumor	1	831	Male	16.94	Matched	NA	Alive	Lymph Node	1.72939619	50
prad_mcspc_mskcc_2020	P-0020750	P-0020750-T01-IM6	56	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1004	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.13	Stable	635438	2	PRAD	13.39	YES	YES	YES	No	440	NA	Tumor	1	897	Male	16.67	Matched	NA	Alive	Prostate	1.72939619	30
prad_mcspc_mskcc_2020	P-0020784	P-0020784-T01-IM6	75	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.0413	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.06	Stable	639627	2	PRAD	14.52	YES	YES	YES	No	3	NA	Tumor	1	799	Male	14.52	Matched	NA	Alive	Bone	1.72939619	20
prad_mcspc_mskcc_2020	P-0020792	P-0020792-T01-IM6	62	Yes	NO	3+4	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.2393	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.85	Stable	638059	4	PRAD	15.48	YES	YES	YES	No	10	White	Tumor	1	283	Male	0.52	Matched	NA	Alive	Lymph Node	3.45879238	80
prad_mcspc_mskcc_2020	P-0020812	P-0020812-T02-IM6	71	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1832	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	1.24	Stable	655300	6	PRAD	29.27	YES	YES	YES	No	34	White	Tumor	1	467	Male	15.6	Matched	NA	Alive	Prostate	5.18818857	30
prad_mcspc_mskcc_2020	P-0020843	P-0020843-T01-IM6	66	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.2404	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	1.42	Stable	638596	1	PRAD	28.97	YES	YES	YES	No	5000	White	Tumor	1	515	Male	5.55	Matched	NA	Dead	Prostate	0.864698095	60
prad_mcspc_mskcc_2020	P-0020847	P-0020847-T02-IM6	71	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0962	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.26	Stable	659454	NA	PRAD	19.77	YES	YES	YES	No	30	White	Tumor	1	657	Male	18.23	Matched	NA	Alive	Prostate	0	10
prad_mcspc_mskcc_2020	P-0021239	P-0021239-T01-IM6	74	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0091	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.12	Stable	648316	4	PRAD	31.3	YES	NO	YES	No	4	White	Tumor	1	681	Male	28.55	Matched	NA	Alive	Prostate	3.45879238	30
prad_mcspc_mskcc_2020	P-0021241	P-0021241-T01-IM6	60	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1258	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.2	Stable	649798	1	PRAD	12.55	YES	YES	YES	No	25	White	Tumor	1	678	Male	7.61	Matched	NA	Alive	Prostate	0.864698095	40
prad_mcspc_mskcc_2020	P-0021287	P-0021287-T01-IM6	55	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.1387	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.07	Stable	652208	NA	PRAD	28.03	YES	YES	YES	No	7	NA	Tumor	1	617	Male	11.26	Matched	NANote: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.NA	Alive	Bone	0	10
prad_mcspc_mskcc_2020	P-0021482	P-0021482-T01-IM6	73	No	NO	<7	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.1334	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.18	Stable	662808	2	PRAD	18	YES	YES	YES	No	3	White	Tumor	1	630	Male	15.53	Matched	NA	Alive	Lymph Node	1.72939619	30
prad_mcspc_mskcc_2020	P-0021486	P-0021486-T01-IM6	71	No	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.1853	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.13	Stable	659200	4	PRAD	15.43	YES	YES	YES	No	8	White	Tumor	1	657	Male	11.29	Matched	NA	Alive	Lung	3.45879238	30
prad_mcspc_mskcc_2020	P-0021525	P-0021525-T01-IM6	69	Yes	NO	8	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.0073	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0	Stable	657392	6	PRAD	13.71	YES	YES	YES	No	4	White	Tumor	1	962	Male	13.71	Matched	NANote: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.NA	Alive	Bone	5.18818857	40
prad_mcspc_mskcc_2020	P-0021577	P-0021577-T01-IM6	64	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.2282	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.33	Stable	665518	2	PRAD	26.33	YES	YES	YES	No	70	White	Tumor	1	660	Male	21.45	Matched	Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	Alive	Prostate	1.72939619	30
prad_mcspc_mskcc_2020	P-0021603	P-0021603-T01-IM6	61	Yes	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.2428	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.58	Stable	662287	5	PRAD	13.94	YES	YES	YES	No	55	White	Tumor	1	615	Male	13.94	Matched	NA	Alive	Other soft tissue	4.323490475	40
prad_mcspc_mskcc_2020	P-0021711	P-0021711-T01-IM6	82	No	NO	NA	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.0043	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0	Stable	666020	2	PRAD	14.74	YES	YES	YES	No	NA	White	Tumor	1	522	Male	13.45	Matched	NANote: Low tumor content (approximately 20% or less).  Negative copy number results, as well as low (stable) MSIsensor scores, should be interpreted with caution. Additional mutation or structural variant may not be detected due to low tumor content.NA	Alive	Bone	1.72939619	10
prad_mcspc_mskcc_2020	P-0021728	P-0021728-T01-IM6	59	Yes	YES	4+3	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.1256	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.07	Stable	666191	2	PRAD	24.07	YES	YES	YES	No	3	NA	Tumor	1	735	Male	24.07	Matched	Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	Alive	Bone	1.72939619	20
prad_mcspc_mskcc_2020	P-0021823	P-0021823-T01-IM6	72	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.0248	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0	Stable	665596	5	PRAD	32.03	YES	YES	YES	No	3	White	Tumor	1	800	Male	32.03	Matched	NA	Alive	Lung	4.323490475	10
prad_mcspc_mskcc_2020	P-0021874	P-0021874-T01-IM6	64	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1973	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). This result is for investigational use only. See MSI note below.	0.13	Stable	663211	2	PRAD	26.03	YES	YES	YES	No	735	NA	Tumor	1	987	Male	10.97	Matched	NANote: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.NA	Alive	Prostate	1.72939619	20
prad_mcspc_mskcc_2020	P-0021894	P-0021894-T02-IM6	64	No	NO	3+4	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.0941	IMPACT468	MSKCC	No	MICROSATELLITE INSTABILITY-HIGH (MSI-H). See MSI note below.	10.14	Instable	958018	41	PRAD	9.61	YES	YES	YES	No	9	NA	Tumor	1	605	Male	9.61	Matched	NA	Alive	Lung	35.45262189	20
prad_mcspc_mskcc_2020	P-0021922	P-0021922-T01-IM6	<45	No	NO	NA	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.2774	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	1.05	Stable	673329	3	PRAD	31.61	YES	YES	YES	No	89	White	Tumor	1	651	Male	12.13	Matched	NA	Alive	Lymph Node	2.594094285	70
prad_mcspc_mskcc_2020	P-0022092	P-0022092-T01-IM6	65	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.1925	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.14	Stable	677126	2	PRAD	19.23	YES	YES	YES	No	91	White	Tumor	1	504	Male	16.53	Matched	NA	Alive	Prostate	1.72939619	40
prad_mcspc_mskcc_2020	P-0022114	P-0022114-T02-IM6	73	No	NO	NA	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.2782	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.68	Stable	751512	4	PRAD	17.83	YES	YES	YES	No	564	White	Tumor	1	565	Male	13.77	Matched	NA	Dead	Lymph Node	3.45879238	40
prad_mcspc_mskcc_2020	P-0022120	P-0022120-T01-IM6	54	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.2595	IMPACT468	MSKCC	Yes	MICROSATELLITE INSTABILITY-HIGH (MSI-H). See MSI note below.	19.66	Instable	677170	33	PRAD	25.33	YES	YES	YES	No	71	White	Tumor	1	712	Male	18.6	Matched	NA	Alive	Prostate	28.53503713	30
prad_mcspc_mskcc_2020	P-0022252	P-0022252-T01-IM6	67	No	NO	NA	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.2897	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.39	Stable	682435	4	PRAD	14.84	YES	YES	YES	No	7	White	Tumor	1	828	Male	14.45	Matched	Note: Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	Alive	Lymph Node	3.45879238	60
prad_mcspc_mskcc_2020	P-0022383	P-0022383-T01-IM6	68	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0642	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.23	Stable	686465	7	PRAD	17	YES	NO	YES	No	29	White	Tumor	1	625	Male	17	Matched	NA	Alive	Prostate	6.052886665	10
prad_mcspc_mskcc_2020	P-0022406	P-0022406-T01-IM6	71	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.0742	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.05	Stable	686433	NA	PRAD	14.27	YES	YES	YES	No	18	Black or African American	Tumor	1	818	Male	12.68	Matched	NA	Alive	Bone	0	20
prad_mcspc_mskcc_2020	P-0022439	P-0022439-T01-IM6	54	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.1254	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	688771	1	PRAD	23.1	YES	YES	YES	No	294	Black or African American	Tumor	1	761	Male	23	Matched	NA	Alive	Prostate	0.864698095	20
prad_mcspc_mskcc_2020	P-0022557	P-0022557-T01-IM6	72	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.4366	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.57	Stable	705421	2	PRAD	26.9	YES	YES	YES	No	273	White	Tumor	1	777	Male	12.7	Matched	NA	Alive	Prostate	1.72939619	60
prad_mcspc_mskcc_2020	P-0022672	P-0022672-T01-IM6	73	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.1571	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.28	Stable	698494	3	PRAD	3.4	YES	YES	YES	No	105	Other	Tumor	1	750	Male	0	Matched	NA	Alive	Lymph Node	2.594094285	30
prad_mcspc_mskcc_2020	P-0022700	P-0022700-T01-IM6	63	No	NO	3+4	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.1853	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.29	Stable	694453	1	PRAD	14.26	YES	YES	YES	No	5	White	Tumor	1	880	Male	14.26	Matched	NA	Alive	Prostate	0.864698095	40
prad_mcspc_mskcc_2020	P-0022778	P-0022778-T01-IM6	55	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.0931	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.98	Stable	700533	2	PRAD	15.32	YES	YES	YES	No	208	NA	Tumor	1	633	Male	15.32	Matched	NA	Alive	Prostate	1.72939619	70
prad_mcspc_mskcc_2020	P-0022798	P-0022798-T01-IM6	68	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0986	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.25	Stable	700524	4	PRAD	31.03	YES	YES	YES	No	9	White	Tumor	1	951	Male	30.37	Matched	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 8p.	Alive	Prostate	3.45879238	30
prad_mcspc_mskcc_2020	P-0022825	P-0022825-T01-IM6	>85	No	NO	NA	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.5218	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.73	Stable	700598	3	PRAD	6.11	YES	YES	YES	No	50	White	Tumor	1	642	Male	6.11	Matched	Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 13q13-22.	Dead	Bone	2.594094285	40
prad_mcspc_mskcc_2020	P-0022905	P-0022905-T01-IM6	69	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0640	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.05	Stable	703940	NA	PRAD	21.94	YES	YES	YES	No	181	White	Tumor	1	660	Male	21.94	Matched	Note: No alterations identified in the context of adequate tumor content .Silent mutations identified were present in high percentage. More comprehensive testing could be valuable.	Alive	Bone	0	10
prad_mcspc_mskcc_2020	P-0022911	P-0022911-T01-IM6	70	No	NO	3+4	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0080	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	703941	2	PRAD	17.03	YES	YES	YES	No	9	White	Tumor	1	597	Male	17.03	Matched	NANote: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.NA	Alive	Bone	1.72939619	10
prad_mcspc_mskcc_2020	P-0023027	P-0023027-T01-IM6	71	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0167	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.05	Stable	712323	NA	PRAD	26.63	YES	NO	YES	No	7	White	Tumor	1	894	Male	13.06	Matched	NANote: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.NA	Alive	Bone	0	10
prad_mcspc_mskcc_2020	P-0023060	P-0023060-T01-IM6	78	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.2229	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.44	Stable	713377	4	PRAD	27.33	YES	NO	YES	No	1818	NA	Tumor	1	646	Male	8.53	Matched	NA	Dead	Prostate	3.45879238	40
prad_mcspc_mskcc_2020	P-0023249	P-0023249-T01-IM6	62	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.3823	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.71	Stable	713370	1	PRAD	34.43	YES	YES	YES	No	489	White	Tumor	1	146	Male	18.94	Matched	NANote: Please note that this sample shows low overall sequencing coverage (146X), raising the risk of false negative results.  We can confirm the presence of the genomic alterations outlined in the report but additional mutations and copy number changes 	Alive	Prostate	0.864698095	40
prad_mcspc_mskcc_2020	P-0023276	P-0023276-T01-IM6	60	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.0485	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.06	Stable	718613	2	PRAD	13.33	YES	YES	YES	No	2019	NA	Tumor	1	695	Male	6.68	Matched	NA	Alive	Prostate	1.72939619	30
prad_mcspc_mskcc_2020	P-0023401	P-0023401-T01-IM6	64	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.2999	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.74	Stable	718943	3	PRAD	17.03	YES	YES	YES	No	29	White	Tumor	1	671	Male	7.21	Matched	NA	Dead	Bone	2.594094285	30
prad_mcspc_mskcc_2020	P-0023550	P-0023550-T01-IM6	68	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0254	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	722923	NA	PRAD	1.26	YES	YES	YES	No	117	White	Tumor	1	608	Male	0.8	Matched	NANote: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.NA	Alive	Prostate	0	20
prad_mcspc_mskcc_2020	P-0023769	P-0023769-T01-IM6	58	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0949	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	NA	3	PRAD	54.73	YES	YES	NO	No	141	White	Tumor	1	317	Male	54.73	Matched	NA	Alive	Prostate	2.594094285	20
prad_mcspc_mskcc_2020	P-0023838	P-0023838-T01-IM6	67	Yes	NO	<7	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.3990	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.19	Stable	733018	3	PRAD	11.45	YES	NO	YES	No	3	NA	Tumor	1	371	Male	0.73	Matched	NA	Alive	Lymph Node	2.594094285	40
prad_mcspc_mskcc_2020	P-0023866	P-0023866-T01-IM6	62	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.3089	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	1.29	Stable	730141	4	PRAD	20.71	YES	YES	YES	No	16	White	Tumor	1	705	Male	18.71	Matched	NANote: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p34-36, 2p16-22, 16q13-24, and 19p13.3-13.12.NA	Alive	Lymph Node	3.45879238	40
prad_mcspc_mskcc_2020	P-0023874	P-0023874-T01-IM6	84	Yes	NO	3+4	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.0011	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	738607	3	PRAD	13.1	YES	YES	YES	No	10	NA	Tumor	1	348	Male	5.36	Matched	NANote: Low tumor content (approximately 20% or less).  Negative copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution. Additional mutations may not be detected due to low tumor content.NA	Alive	Bone	2.594094285	10
prad_mcspc_mskcc_2020	P-0023967	P-0023967-T01-IM6	>85	No	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.0425	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	751430	1	PRAD	11.77	YES	YES	YES	No	12	NA	Tumor	1	587	Male	11.77	Matched	Note: Low tumor content (approximately 20% or less). Negative copy number and structural variant results should be interpreted with caution. Additional mutations may not be detected due to low tumor content.	Alive	Lymph Node	0.864698095	10
prad_mcspc_mskcc_2020	P-0023988	P-0023988-T01-IM6	65	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1894	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.05	Stable	633614	3	PRAD	18.45	YES	YES	YES	No	147	White	Tumor	1	626	Male	5.7	Matched	NA	Dead	Prostate	2.594094285	30
prad_mcspc_mskcc_2020	P-0024076	P-0024076-T01-IM6	67	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.0423	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.14	Stable	749051	2	PRAD	21	YES	YES	YES	No	2222	White	Tumor	1	808	Male	9.27	Matched	NA	Dead	Prostate	1.72939619	40
prad_mcspc_mskcc_2020	P-0024080	P-0024080-T01-IM6	65	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.4957	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.27	Stable	754021	3	PRAD	62	YES	YES	YES	No	11	NA	Tumor	1	740	Male	50.32	Matched	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arms 3q and 8q.	Alive	Lung	2.594094285	50
prad_mcspc_mskcc_2020	P-0024087	P-0024087-T01-IM6	78	No	NO	NA	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0785	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	749159	1	PRAD	19.57	YES	YES	YES	No	4	White	Tumor	1	760	Male	19.57	Matched	NA	Alive	Bone	0.864698095	20
prad_mcspc_mskcc_2020	P-0024140	P-0024140-T01-IM6	58	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.2308	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	752166	1	PRAD	13.97	YES	YES	YES	No	62	White	Tumor	1	472	Male	13.81	Matched	NA	Alive	Prostate	0.864698095	30
prad_mcspc_mskcc_2020	P-0024248	P-0024248-T01-IM6	70	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.3259	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	750942	NA	PRAD	17.77	YES	YES	YES	No	24	White	Tumor	1	301	Male	10.42	Matched	Note: No alterations identified in the context of adequate tumor content .Silent mutations identified were present in high percentage.More comprehensive testing could be valuable.	Dead	Prostate	0	20
prad_mcspc_mskcc_2020	P-0024249	P-0024249-T01-IM6	75	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.3773	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.98	Stable	751482	5	PRAD	15.17	YES	YES	YES	No	28	White	Tumor	1	700	Male	13.68	Matched	NA	Alive	Prostate	4.323490475	30
prad_mcspc_mskcc_2020	P-0024316	P-0024316-T01-IM6	65	Yes	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0045	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.06	Stable	755720	4	PRAD	17.47	YES	YES	YES	No	89	White	Tumor	1	786	Male	4.52	Matched	NANote: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.NA	Alive	Prostate	3.45879238	10
prad_mcspc_mskcc_2020	P-0024427	P-0024427-T01-IM6	72	No	YES	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0317	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.13	Stable	757667	2	PRAD	21.53	YES	YES	YES	No	31	White	Tumor	1	740	Male	17.64	Matched	Note: Copy number profile is suggestive of broad copy number loss on Chromosome 16q22-24.	Alive	Prostate	1.72939619	40
prad_mcspc_mskcc_2020	P-0024461	P-0024461-T01-IM6	62	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1547	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	754680	4	PRAD	25.67	YES	YES	YES	No	496	White	Tumor	1	694	Male	25.67	Matched	NA	Alive	Prostate	3.45879238	30
prad_mcspc_mskcc_2020	P-0024522	P-0024522-T01-IM6	62	No	NO	<7	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.1600	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	757164	2	PRAD	14.84	YES	YES	YES	No	5	Black or African American	Tumor	1	567	Male	8.4	Matched	NA	Dead	Bone	1.72939619	30
prad_mcspc_mskcc_2020	P-0024600	P-0024600-T01-IM6	82	No	YES	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.1683	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.35	Stable	759340	5	PRAD	20.94	YES	YES	YES	No	37	NA	Tumor	1	317	Male	20.94	Matched	NA	Alive	Prostate	4.323490475	50
prad_mcspc_mskcc_2020	P-0024660	P-0024660-T01-IM6	65	Yes	NO	NA	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1336	IMPACT468	MSKCC	Yes	MICROSATELLITE INSTABILITY-HIGH (MSI-H). See MSI note below.	29.72	Instable	762942	65	PRAD	29.94	YES	YES	YES	No	701	White	Tumor	1	779	Male	2.04	Matched	NA	Alive	Bone	56.20537617	40
prad_mcspc_mskcc_2020	P-0024679	P-0024679-T01-IM6	59	No	YES	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.1836	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.12	Stable	760777	1	PRAD	21.84	YES	YES	YES	No	22	NA	Tumor	1	616	Male	18.41	Matched	NA	Alive	Prostate	0.864698095	20
prad_mcspc_mskcc_2020	P-0024693	P-0024693-T01-IM6	71	Yes	NO	<7	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.2879	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.19	Stable	759297	2	PRAD	11.73	YES	YES	YES	No	5	White	Tumor	1	817	Male	7.42	Matched	NA	Alive	Liver	1.72939619	30
prad_mcspc_mskcc_2020	P-0024898	P-0024898-T01-IM6	<45	No	NO	NA	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.0666	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.12	Stable	863961	2	PRAD	13.9	YES	YES	YES	No	264	White	Tumor	1	527	Male	10.87	Matched	NA	Dead	Lymph Node	1.72939619	30
prad_mcspc_mskcc_2020	P-0025044	P-0025044-T01-IM6	76	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.2299	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.78	Stable	877565	3	PRAD	10.65	YES	YES	YES	No	11	White	Tumor	1	832	Male	9.9	Matched	NA	Alive	Other soft tissue	2.594094285	40
prad_mcspc_mskcc_2020	P-0025086	P-0025086-T01-IM6	69	Yes	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.2150	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	877448	2	PRAD	29.57	YES	YES	YES	No	50	White	Tumor	1	727	Male	29.57	Matched	NA	Alive	Lymph Node	1.72939619	20
prad_mcspc_mskcc_2020	P-0025087	P-0025087-T01-IM6	59	Yes	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.1431	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.25	Stable	885579	1	PRAD	22.03	YES	YES	YES	No	10	White	Tumor	1	719	Male	22.03	Matched	Note: Copy number profile is suggestive of multiple chromosome level losses.	Alive	Bone	0.864698095	20
prad_mcspc_mskcc_2020	P-0025097	P-0025097-T01-IM6	52	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1850	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.71	Stable	880090	7	PRAD	19.83	YES	YES	YES	No	48	NA	Tumor	1	804	Male	19.6	Matched	NA	Alive	Lymph Node	6.052886665	50
prad_mcspc_mskcc_2020	P-0025137	P-0025137-T01-IM6	76	Yes	NO	3+4	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.5137	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	1.51	Stable	875492	3	PRAD	9.58	YES	YES	YES	No	3	NA	Tumor	1	729	Male	9.45	Matched	NA	Alive	Other soft tissue	2.594094285	50
prad_mcspc_mskcc_2020	P-0025138	P-0025138-T02-IM6	73	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.2242	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.46	Stable	909534	3	PRAD	18.77	YES	YES	YES	No	10	NA	Tumor	1	1011	Male	16.43	Matched	NA	Alive	Liver	2.594094285	50
prad_mcspc_mskcc_2020	P-0025150	P-0025150-T01-IM6	47	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.1879	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.27	Stable	885392	2	PRAD	28	YES	YES	YES	No	189	NA	Tumor	1	574	Male	20.6	Matched	NA	Alive	Prostate	1.72939619	20
prad_mcspc_mskcc_2020	P-0025153	P-0025153-T01-IM6	52	No	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1942	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.55	Stable	885359	4	PRAD	19.67	YES	YES	YES	No	1106	Black or African American	Tumor	1	874	Male	6.71	Matched	NA	Alive	Lymph Node	3.45879238	50
prad_mcspc_mskcc_2020	P-0025222	P-0025222-T01-IM6	54	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.1997	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.32	Stable	885397	5	PRAD	42.77	YES	YES	YES	No	11	NA	Tumor	1	337	Male	15.74	Matched	NANote: Copy number profile is suggestive of broad copy number loss on Chromosome arms 5q11-31 (including APC), 8p, 9p (including CDKN2A, CDKN2B), 16q22-24, 17p (including TP53), 18q, and 19q13.2-13.4.NA	Alive	Prostate	6.052886665	30
prad_mcspc_mskcc_2020	P-0025276	P-0025276-T01-IM6	66	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.1361	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.06	Stable	884405	7	PRAD	19.87	YES	YES	YES	No	47	Other	Tumor	1	907	Male	18.48	Matched	NA	Alive	Bone	6.052886665	20
prad_mcspc_mskcc_2020	P-0025329	P-0025329-T01-IM6	81	No	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.0044	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.06	Stable	888265	3	PRAD	11.55	YES	YES	YES	No	12	White	Tumor	1	949	Male	11.39	Matched	NANote: Low tumor content (approximately 20% or less). Negative mutation, MSIsensor, copy number and structural variant results should be interpreted with caution.NA	Alive	Lymph Node	2.594094285	20
prad_mcspc_mskcc_2020	P-0025364	P-0025364-T01-IM6	74	No	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.1478	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.91	Stable	889760	2	PRAD	24.71	YES	YES	YES	No	6	White	Tumor	1	670	Male	24.71	Matched	NA	Alive	Prostate	1.72939619	30
prad_mcspc_mskcc_2020	P-0025494	P-0025494-T01-IM6	77	No	NO	NA	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.6671	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.56	Stable	NA	1	PRAD	21.57	YES	NO	NO	No	201	White	Tumor	1	567	Male	6.13	Matched	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q11-24 including MYC.	Dead	Lymph Node	0.864698095	50
prad_mcspc_mskcc_2020	P-0025650	P-0025650-T01-IM6	71	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.1366	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.39	Stable	885550	3	PRAD	13.4	YES	YES	YES	No	406	NA	Tumor	1	997	Male	4.84	Matched	NA	Alive	Prostate	2.594094285	70
prad_mcspc_mskcc_2020	P-0025676	P-0025676-T01-IM6	76	Yes	NO	<7	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.4941	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.77	Stable	897376	3	PRAD	19.03	YES	YES	YES	No	8	White	Tumor	1	741	Male	19.03	Matched	NANote: Copy number profile from IMPACT assay and allele specific copy number analysis by FACETS suggests copy neutral loss of heterozygosity on Chromosome arm 11q22.3-11q24, including ATM. The results by FACETS are for investigational use. Confirmation o	Alive	Other soft tissue	2.594094285	90
prad_mcspc_mskcc_2020	P-0025705	P-0025705-T01-IM6	73	NA	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.0209	IMPACT468	MSKCC	Yes	N/A	4.51	Do not report	895719	2	PRAD	29.94	YES	YES	YES	No	253	White	Tumor	1	150	Male	12.03	Matched	The MSIsensor score is not reported due to lower than expected overall coverage.	Dead	Bone	1.72939619	30
prad_mcspc_mskcc_2020	P-0025718	P-0025718-T01-IM6	67	No	YES	3+4	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0364	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	899953	NA	PRAD	14.48	YES	YES	YES	No	175	White	Tumor	1	680	Male	14.48	Matched	Note: No alterations identified in the context of adequate tumor content by morphologic review. Silent mutations are present. More comprehensive testing could be valuable.	Alive	Prostate	0	30
prad_mcspc_mskcc_2020	P-0025759	P-0025759-T01-IM6	66	Yes	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.1502	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	903276	2	PRAD	19.4	YES	YES	YES	No	3	White	Tumor	1	865	Male	13.39	Matched	NA	Alive	Bone	1.72939619	20
prad_mcspc_mskcc_2020	P-0025823	P-0025823-T01-IM6	61	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.4025	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	1.31	Stable	907497	2	PRAD	9.23	YES	YES	YES	No	19	White	Tumor	1	1100	Male	6.17	Matched	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q24.	Alive	Lymph Node	1.72939619	60
prad_mcspc_mskcc_2020	P-0025851	P-0025851-T02-IM6	70	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.3135	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.08	Stable	909583	3	PRAD	19.9	YES	YES	YES	No	24	NA	Tumor	1	600	Male	4.61	Matched	NA	Alive	Prostate	2.594094285	40
prad_mcspc_mskcc_2020	P-0025952	P-0025952-T01-IM6	72	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1839	IMPACT468	MSKCC	Yes	MICROSATELLITE INSTABILITY-HIGH (MSI-H). See MSI note below.	16.93	Instable	907479	59	PRAD	27.5	YES	YES	YES	No	63	White	Tumor	1	575	Male	5.97	Matched	NANote: Copy number profile is suggestive of broad copy number gain on Chromosome arms 1q, 4q35 and Chromosomes 3 and 7.NA	Alive	Lymph Node	51.0171876	80
prad_mcspc_mskcc_2020	P-0026139	P-0026139-T01-IM6	63	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.2811	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.07	Stable	915600	1	PRAD	26.45	YES	NO	YES	No	1	White	Tumor	1	551	Male	26.45	Matched	NA	Alive	Prostate	0.864698095	40
prad_mcspc_mskcc_2020	P-0026237	P-0026237-T01-IM6	63	No	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.1141	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.17	Stable	920112	4	PRAD	24.87	YES	YES	YES	No	288	Other	Tumor	1	390	Male	23.47	Matched	Note: Copy number profile is suggestive of broad copy number gain on Chromosome arm 8q.	Alive	Prostate	3.45879238	30
prad_mcspc_mskcc_2020	P-0026316	P-0026316-T01-IM6	81	No	NO	NA	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1491	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.14	Stable	916902	5	PRAD	25.3	YES	YES	YES	No	846	White	Tumor	1	379	Male	19.68	Matched	NA	Alive	Bone	4.323490475	60
prad_mcspc_mskcc_2020	P-0026355	P-0026355-T01-IM6	58	No	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1271	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.23	Stable	924712	2	PRAD	10.7	YES	YES	YES	No	40	Other	Tumor	1	286	Male	10.6	Matched	NA	Alive	Lung	1.72939619	70
prad_mcspc_mskcc_2020	P-0026409	P-0026409-T01-IM6	>85	No	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.1182	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.25	Stable	924669	5	PRAD	9.8	YES	YES	YES	No	5	White	Tumor	1	1007	Male	1.26	Matched	NANote: Copy number profile is suggestive of broad copy number losses on Chromosome arms 6q15-22, 13q14-24, 16q, 17p, and 20q12.NA	Alive	Bone	4.323490475	70
prad_mcspc_mskcc_2020	P-0026673	P-0026673-T01-IM6	<45	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.1742	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.24	Stable	934679	2	PRAD	9.43	YES	YES	YES	No	831	Black or African American	Tumor	1	484	Male	9.43	Matched	NA	Alive	Lymph Node	1.72939619	50
prad_mcspc_mskcc_2020	P-0026698	P-0026698-T01-IM6	66	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.4826	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.65	Stable	922409	3	PRAD	19.8	YES	YES	YES	No	4	White	Tumor	1	855	Male	19.7	Matched	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 8 and Chromosome arm 1q. Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 13q12-14 and 16q22-23	Alive	Prostate	2.594094285	60
prad_mcspc_mskcc_2020	P-0026750	P-0026750-T01-IM6	66	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.2363	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.19	Stable	936066	1	PRAD	15.71	YES	YES	YES	No	2001	White	Tumor	1	930	Male	15.39	Matched	NA	Alive	Prostate	0.864698095	40
prad_mcspc_mskcc_2020	P-0026774	P-0026774-T01-IM6	64	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.1743	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.15	Stable	935065	3	PRAD	10.77	YES	YES	YES	No	12	White	Tumor	1	652	Male	10.77	Matched	NA	Alive	Lung	2.594094285	40
prad_mcspc_mskcc_2020	P-0026808	P-0026808-T01-IM6	65	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.6022	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	1.2	Stable	937688	5	PRAD	10.83	YES	YES	YES	No	9	White	Tumor	1	823	Male	4.84	Matched	NA	Dead	Lung	4.323490475	60
prad_mcspc_mskcc_2020	P-0026812	P-0026812-T01-IM6	83	No	NO	NA	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.0502	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	937795	1	PRAD	7.61	YES	YES	YES	No	NA	White	Tumor	1	735	Male	7.61	Matched	NA	Alive	Bone	0.864698095	40
prad_mcspc_mskcc_2020	P-0026855	P-0026855-T01-IM6	65	Yes	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.3499	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.93	Stable	938970	5	PRAD	8.84	YES	YES	YES	No	3	White	Tumor	1	1039	Male	1.03	Matched	Note: Copy number profile is suggestive of a fragmented genome.	Alive	Lymph Node	4.323490475	60
prad_mcspc_mskcc_2020	P-0026861	P-0026861-T01-IM6	>85	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1286	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.33	Stable	939202	5	PRAD	7.9	YES	YES	YES	No	1116	White	Tumor	1	808	Male	7.9	Matched	NA	Alive	Prostate	4.323490475	40
prad_mcspc_mskcc_2020	P-0027036	P-0027036-T01-IM6	64	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.1755	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	949251	4	PRAD	33.53	YES	YES	YES	No	84	White	Tumor	1	740	Male	6.16	Matched	NA	Alive	Prostate	3.45879238	20
prad_mcspc_mskcc_2020	P-0027160	P-0027160-T01-IM6	69	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.2719	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.39	Stable	949348	2	PRAD	36.2	YES	YES	YES	No	94	Black or African American	Tumor	1	418	Male	5.03	Matched	Assessment of the copy number profile is limited by increased background noise.False negatives cannot be ruled out. Confirmation of copy number changes by alternate methods is suggested if clinically indicated.	Alive	Prostate	1.72939619	30
prad_mcspc_mskcc_2020	P-0027193	P-0027193-T01-IM6	65	No	YES	NA	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.0254	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	956082	3	PRAD	5.84	YES	YES	YES	No	939	White	Tumor	1	822	Male	3.71	Matched	NA	Dead	Lymph Node	2.594094285	20
prad_mcspc_mskcc_2020	P-0027245	P-0027245-T01-IM6	61	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.1060	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.3	Stable	949229	4	PRAD	58.87	YES	NO	YES	No	40	White	Tumor	1	787	Male	23.48	Matched	NA	Alive	Prostate	3.45879238	20
prad_mcspc_mskcc_2020	P-0027380	P-0027380-T01-IM6	59	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0223	IMPACT468	MSKCC	No	MICROSATELLITE INSTABILITY-INDETERMINATE. See MSI note below.	5.39	Indeterminate	963251	76	PRAD	20.26	YES	YES	YES	No	13	White	Tumor	1	470	Male	20.26	Matched	NA	Alive	Prostate	65.71705522	20
prad_mcspc_mskcc_2020	P-0027453	P-0027453-T01-IM6	60	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.2367	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.22	Stable	963271	1	PRAD	9.9	YES	YES	YES	No	8	White	Tumor	1	808	Male	8.52	Matched	NA	Alive	Prostate	0.864698095	80
prad_mcspc_mskcc_2020	P-0027466	P-0027466-T01-IM6	75	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.2552	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.07	Stable	963248	5	PRAD	8.13	YES	YES	YES	No	10	White	Tumor	1	721	Male	8.13	Matched	NA	Alive	Other soft tissue	4.323490475	40
prad_mcspc_mskcc_2020	P-0027823	P-0027823-T01-IM6	70	Yes	NO	<7	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.0289	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.07	Stable	972196	3	PRAD	7.5	YES	NO	YES	No	9	White	Tumor	1	959	Male	7.5	Matched	NA	Alive	Lymph Node	2.594094285	30
prad_mcspc_mskcc_2020	P-0027874	P-0027874-T01-IM6	65	No	NO	NA	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.2669	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.59	Stable	972194	3	PRAD	16.93	YES	YES	YES	No	177	White	Tumor	1	860	Male	3.45	Matched	NANote: Copy number profile is suggestive of broad copy number gains on Chromosome arms 3q22-28, 8q11-24.21 and 10q11-21. Note: Copy number profile is suggestive of broad copy number losses on Chromosome arms 10q, 17p and 17q11-21.31.NA	Alive	Lymph Node	2.594094285	50
prad_mcspc_mskcc_2020	P-0028080	P-0028080-T01-IM6	77	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0363	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	996053	NA	PRAD	10.6	NO	NO	YES	No	38	White	Tumor	1	742	Male	4.74	Matched	NA	Alive	Prostate	0	20
prad_mcspc_mskcc_2020	P-0028160	P-0028160-T01-IM6	56	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1537	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.2	Stable	984843	6	PRAD	22.33	YES	YES	YES	No	59	White	Tumor	1	311	Male	19.42	Matched	NA	Alive	Prostate	5.18818857	40
prad_mcspc_mskcc_2020	P-0028167	P-0028167-T01-IM6	71	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1986	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.06	Stable	984875	4	PRAD	6.48	YES	YES	YES	No	282	White	Tumor	1	533	Male	6.32	Matched	NA	Alive	Liver	3.45879238	40
prad_mcspc_mskcc_2020	P-0028306	P-0028306-T01-IM6	73	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1771	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.21	Stable	988571	6	PRAD	26.33	YES	YES	YES	No	26	White	Tumor	1	745	Male	23.61	Matched	NA	Alive	Prostate	5.18818857	50
prad_mcspc_mskcc_2020	P-0028551	P-0028551-T01-IM6	75	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.2064	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.07	Stable	996537	1	PRAD	19.1	YES	YES	YES	No	259	White	Tumor	1	893	Male	9.68	Matched	NA	Dead	Prostate	0.864698095	30
prad_mcspc_mskcc_2020	P-0028587	P-0028587-T01-IM6	46	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0513	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	996633	9	PRAD	10.1	YES	YES	YES	No	16	White	Tumor	1	357	Male	7.13	Matched	NA	Alive	Prostate	7.782282855	30
prad_mcspc_mskcc_2020	P-0028654	P-0028654-T01-IM6	61	No	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1053	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.11	Stable	999390	3	PRAD	22.39	YES	YES	YES	No	24	White	Tumor	1	611	Male	22.39	Matched	NA	Alive	Prostate	2.594094285	20
prad_mcspc_mskcc_2020	P-0028700	P-0028700-T01-IM6	65	No	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.0429	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	1000561	2	PRAD	7.2	YES	YES	YES	No	15	White	Tumor	1	660	Male	6.68	Matched	NANote: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.NA	Alive	Bone	1.72939619	20
prad_mcspc_mskcc_2020	P-0028741	P-0028741-T01-IM6	>85	No	NO	NA	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.3001	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.29	Stable	999324	5	PRAD	27.57	YES	YES	YES	No	NA	White	Tumor	1	540	Male	27.57	Matched	NA	Alive	Prostate	4.323490475	20
prad_mcspc_mskcc_2020	P-0029028	P-0029028-T01-IM6	73	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.0465	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.54	Stable	NA	1	PRAD	22.67	YES	NO	NO	No	33	White	Tumor	1	780	Male	22.67	Matched	NA	Alive	Prostate	0.864698095	50
prad_mcspc_mskcc_2020	P-0029087	P-0029087-T01-IM6	72	No	NO	NA	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1457	IMPACT468	MSKCC	Yes	MICROSATELLITE INSTABILITY-INDETERMINATE. See MSI note below.	3.09	Indeterminate	1015886	23	PRAD	79.9	YES	YES	YES	No	10	White	Tumor	1	499	Male	32.93	Matched	NA	Alive	Lung	19.88805618	50
prad_mcspc_mskcc_2020	P-0029106	P-0029106-T01-IM6	73	NA	NO	3+4	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.0672	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.11	Stable	1019432	3	PRAD	5.03	YES	YES	YES	No	6	Black or African American	Tumor	1	886	Male	5.03	Matched	NA	Alive	Lymph Node	2.594094285	40
prad_mcspc_mskcc_2020	P-0029164	P-0029164-T01-IM6	71	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0331	IMPACT468	MSKCC	Yes	MICROSATELLITE INSTABILITY-HIGH (MSI-H). See MSI note below.	25.63	Instable	1015785	45	PRAD	14.03	YES	YES	YES	No	822	Other	Tumor	1	288	Male	4.68	Matched	NA	Alive	Prostate	38.91141427	90
prad_mcspc_mskcc_2020	P-0029248	P-0029248-T01-IM6	53	No	NO	<7	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.0129	IMPACT468	MSKCC	No	MICROSATELLITE INSTABILITY-HIGH (MSI-H). See MSI note below.	22.38	Instable	1016822	39	PRAD	5.84	YES	YES	YES	No	15	White	Tumor	1	771	Male	5.84	Matched	NA	Alive	Liver	34.5879238	40
prad_mcspc_mskcc_2020	P-0029284	P-0029284-T01-IM6	70	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.1111	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.28	Stable	1017983	6	PRAD	0.96	YES	YES	YES	No	1075	White	Tumor	1	645	Male	0.96	Matched	NA	Alive	Prostate	4.323490475	60
prad_mcspc_mskcc_2020	P-0029405	P-0029405-T01-IM6	76	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0573	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	1021067	2	PRAD	6.43	YES	YES	YES	No	29	White	Tumor	1	715	Male	6.43	Matched	NA	Alive	Prostate	1.72939619	40
prad_mcspc_mskcc_2020	P-0029523	P-0029523-T01-IM6	84	No	NO	NA	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.2290	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.45	Stable	1026084	2	PRAD	13.26	YES	YES	YES	No	95	White	Tumor	1	477	Male	13.26	Matched	Note: Copy number profile is suggestive of broad copy number gains on Chromosome arms 8q and Chromosome 9.	Alive	Lymph Node	1.72939619	40
prad_mcspc_mskcc_2020	P-0029645	P-0029645-T01-IM6	55	No	YES	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1429	IMPACT468	MSKCC	Yes	MICROSATELLITE INSTABILITY-HIGH (MSI-H). See MSI note below.	12.58	Instable	1033164	27	PRAD	19.87	YES	YES	YES	No	63	Other	Tumor	1	665	Male	10.4	Matched	NA	Alive	Prostate	23.34684856	30
prad_mcspc_mskcc_2020	P-0030109	P-0030109-T01-IM6	56	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1301	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	1039372	2	PRAD	30.46	YES	YES	YES	No	156	White	Tumor	1	438	Male	5.13	Matched	NA	Dead	Prostate	1.72939619	40
prad_mcspc_mskcc_2020	P-0030261	P-0030261-T01-IM6	74	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.0446	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	1046358	1	PRAD	15.06	YES	YES	YES	No	50	Black or African American	Tumor	1	510	Male	15.06	Matched	NA	Alive	Prostate	0.864698095	40
prad_mcspc_mskcc_2020	P-0030381	P-0030381-T01-IM6	64	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.1047	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.38	Stable	1051734	3	PRAD	4.77	YES	YES	YES	No	4	White	Tumor	1	594	Male	4.77	Matched	NANote: Copy number profile is suggestive of broad copy number loss on Chromosome arms 1p36, 5q11-22, 6q15-22, 13q and 16q.NA	Alive	Lung	2.594094285	80
prad_mcspc_mskcc_2020	P-0030445	P-0030445-T01-IM6	63	No	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.0000	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	1016919	2	PRAD	5.55	YES	YES	YES	No	5	Black or African American	Tumor	1	632	Male	5.55	Matched	NANote: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.NA	Alive	Bone	1.72939619	20
prad_mcspc_mskcc_2020	P-0030465	P-0030465-T01-IM6	66	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0001	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	1054243	6	PRAD	10.94	YES	YES	YES	No	11	White	Tumor	1	554	Male	10.94	Matched	NANote: Low tumor content (approximately 20% or less).  Negative mutation, copy number and structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.NA	Alive	Prostate	5.18818857	10
prad_mcspc_mskcc_2020	P-0030580	P-0030580-T01-IM6	66	Yes	NO	8	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.4318	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.6	Stable	1056278	2	PRAD	4.53	YES	YES	YES	No	6	White	Tumor	1	591	Male	4	Matched	NA	Alive	Lymph Node	1.72939619	30
prad_mcspc_mskcc_2020	P-0030801	P-0030801-T01-IM6	57	Yes	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.0456	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.13	Stable	1066803	3	PRAD	3.97	YES	YES	YES	No	12	White	Tumor	1	811	Male	3.97	Matched	NA	Alive	Lymph Node	2.594094285	30
prad_mcspc_mskcc_2020	P-0031008	P-0031008-T01-IM6	<45	No	NO	NA	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.1303	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	1.09	Stable	1075588	1	PRAD	16.97	YES	YES	YES	No	397	White	Tumor	1	413	Male	10.32	Matched	NA	Alive	Lymph Node	0.864698095	30
prad_mcspc_mskcc_2020	P-0031062	P-0031062-T01-IM6	55	No	NO	NA	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.0929	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	1077077	5	PRAD	6.23	YES	YES	YES	No	4	NA	Tumor	1	804	Male	5.1	Matched	NANote: Copy number profile is suggestive of multiple chromosome arm level losses, including RB1 on Chromosome arm 13q.NA	Alive	Lung	4.323490475	30
prad_mcspc_mskcc_2020	P-0031135	P-0031135-T01-IM6	66	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.4758	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.48	Stable	1081541	10	PRAD	35.07	YES	YES	YES	No	16	White	Tumor	1	346	Male	6	Matched	NA	Alive	Prostate	8.64698095	40
prad_mcspc_mskcc_2020	P-0031137	P-0031137-T01-IM6	68	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1951	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.76	Stable	1082635	3	PRAD	17.03	YES	YES	YES	No	301	White	Tumor	1	564	Male	11.87	Matched	NA	Alive	Prostate	2.594094285	40
prad_mcspc_mskcc_2020	P-0031374	P-0031374-T01-IM6	72	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0228	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.1	Stable	1092563	1	PRAD	6.97	YES	YES	YES	No	6	White	Tumor	1	674	Male	6.9	Matched	NA	Alive	Prostate	0.864698095	30
prad_mcspc_mskcc_2020	P-0031419	P-0031419-T01-IM6	64	No	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.2215	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	1.29	Stable	1091852	4	PRAD	5.43	YES	YES	YES	No	4	White	Tumor	1	756	Male	4.84	Matched	NA	Alive	Lymph Node	3.45879238	40
prad_mcspc_mskcc_2020	P-0031426	P-0031426-T01-IM6	64	No	NO	4+3	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.2036	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.5	Stable	1091748	4	PRAD	18.9	YES	YES	YES	No	14	Black or African American	Tumor	1	680	Male	18.81	Matched	NA	Alive	Lung	3.45879238	50
prad_mcspc_mskcc_2020	P-0031720	P-0031720-T01-IM6	64	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.1710	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.05	Stable	1099643	4	PRAD	2.77	YES	YES	YES	No	6	White	Tumor	1	607	Male	2.77	Matched	NA	Alive	Bone	3.45879238	20
prad_mcspc_mskcc_2020	P-0031769	P-0031769-T01-IM6	66	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0725	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.22	Stable	1105946	2	PRAD	18.2	NO	NO	YES	No	20	White	Tumor	1	868	Male	6.2	Matched	NA	Alive	Prostate	1.72939619	60
prad_mcspc_mskcc_2020	P-0031771	P-0031771-T01-IM6	61	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0000	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	1105952	4	PRAD	13.68	YES	YES	YES	No	4	NA	Tumor	1	615	Male	13.68	Matched	NA	Alive	Prostate	3.45879238	10
prad_mcspc_mskcc_2020	P-0032080	P-0032080-T01-IM6	56	Yes	NO	3+4	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	Low-volume disease	0.0470	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	1116458	1	PRAD	3.2	YES	YES	YES	No	85	Black or African American	Tumor	1	375	Male	1.65	Matched	NA	Alive	Bone	0.864698095	30
prad_mcspc_mskcc_2020	P-0032601	P-0032601-T01-IM6	58	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.0111	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.21	Stable	1136945	2	PRAD	5.47	YES	YES	YES	No	5	NA	Tumor	1	315	Male	4.84	Matched	NA	Alive	Prostate	1.72939619	30
prad_mcspc_mskcc_2020	P-0032757	P-0032757-T01-IM6	81	No	NO	3+4	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.2023	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.12	Stable	1138204	7	PRAD	1.16	YES	YES	YES	No	NA	White	Tumor	1	390	Male	0.42	Matched	NA	Alive	Bone	6.052886665	50
prad_mcspc_mskcc_2020	P-0032799	P-0032799-T01-IM6	58	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.1539	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.06	Stable	1141434	1	PRAD	7.07	YES	YES	YES	No	6	White	Tumor	1	372	Male	7.07	Matched	NA	Alive	Prostate	0.864698095	50
prad_mcspc_mskcc_2020	P-0033010	P-0033010-T01-IM6	66	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	Metastatic recurrence	Metastatic hormone-sensitive	High-volume disease	0.1752	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0.24	Stable	1147146	1	PRAD	1.8	YES	YES	YES	No	6	White	Tumor	1	346	Male	0.26	Matched	NA	Alive	Lymph Node	0.864698095	50
prad_mcspc_mskcc_2020	P-0033105	P-0033105-T01-IM6	71	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.0846	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	0	Stable	NA	1	PRAD	12.67	YES	YES	NO	No	55	White	Tumor	1	541	Male	6.23	Matched	NANote: Low tumor content (approximately 20% or less).  Negative structural variant results, as well as low (stable) MSIsensor scores, should be interpreted with caution.  Additional mutations and copy number alterations may not be detected due to low tum	Alive	Prostate	0.864698095	20
prad_mcspc_mskcc_2020	P-0033226	P-0033226-T01-IM6	64	No	NO	8	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	Low-volume disease	0.2930	IMPACT468	MSKCC	Yes	MICROSATELLITE STABLE (MSS). See MSI note below.	0.39	Stable	NA	3	PRAD	33.94	YES	NO	NO	No	5	White	Tumor	1	264	Male	10.23	Matched	NA	Alive	Prostate	2.594094285	30
prad_mcspc_mskcc_2020	P-0033767	P-0033767-T01-IM6	63	No	NO	9-10	Prostate Cancer	Prostate Adenocarcinoma	De-novo metastatic	Metastatic hormone-sensitive	High-volume disease	0.4174	IMPACT468	MSKCC	No	MICROSATELLITE STABLE (MSS). See MSI note below.	1.08	Stable	NA	5	PRAD	11.1	YES	YES	NO	No	2	White	Tumor	1	754	Male	10.17	Matched	Note: Copy number profile is suggestive of a fragmented genome.	Alive	Liver	4.323490475	80